UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
Report on Form 6-K dated
November 4, 2019
Commission File Number: 1-13546
STMicroelectronics
N.V.
(Name of Registrant)
WTC Schiphol Airport
Schiphol Boulevard 265
1118 BH Schiphol Airport
The Netherlands
(Address of Principal Executive Offices)
Indicate by check mark whether the
registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Indicate by check mark whether the
registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
If “Yes” is marked, indicate
below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- __________
Enclosure: STMicroelectronics
N.V.’s Third Quarter and Nine Months ended September 28, 2019:
|
·
|
Operating and Financial Review and Prospects;
|
|
·
|
Unaudited Interim Consolidated Statements of Income, Statements of Comprehensive Income, Balance
Sheets, Statements of Cash Flow, and Statements of Equity and related Notes for the three and nine months ended September
28, 2019; and
|
|
·
|
Certifications pursuant to Sections 302 (Exhibits 12.1 and 12.2) and 906 (Exhibit 13.1)
of the Sarbanes-Oxley Act of 2002, submitted to the Commission on a voluntary basis.
|
OPERATING AND FINANCIAL REVIEW AND PROSPECTS
Overview
The following discussion should be read
in conjunction with our Unaudited Interim Consolidated Statements of Income, Statements of Comprehensive Income, Balance Sheets,
Statements of Cash Flows and Statements of Equity for the three and nine months ended September 28, 2019 and Notes thereto included
elsewhere in this Form 6-K, and our annual report on Form 20-F for the year ended December 31, 2018 as filed
with the U.S. Securities and Exchange Commission (the “Commission” or the “SEC”) on February 28, 2019 (the
“Form 20-F”). The following discussion contains statements of future expectations and other forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, or Section 21E of the Securities Exchange
Act of 1934, each as amended, particularly in the sections “Business Overview” and “Liquidity and Capital Resources—Financial
Outlook: Capital Investment”. Our actual results may differ significantly from those projected in the forward-looking
statements. For a discussion of factors that might cause future actual results to differ materially from our recent results or
those projected in the forward-looking statements in addition to the factors set forth below, see “Cautionary Note Regarding
Forward-Looking Statements” and “Item 3. Key Information—Risk Factors” included in the Form 20-F.
We assume no obligation to update the forward-looking statements or such risk factors.
Our Management’s Discussion and Analysis
of Financial Position and Results of Operations (“MD&A”) is provided in addition to the accompanying unaudited
interim consolidated financial statements (“Consolidated Financial Statements”) and notes to assist readers in understanding
our results of operations, financial condition and cash flows. Our MD&A is organized as follows:
|
·
|
Critical Accounting Policies using Significant Estimates.
|
|
·
|
Business Overview, a discussion of our business and overall analysis of financial and other relevant
highlights of the three and nine months ended September 28, 2019 designed to provide context for the other sections of the
MD&A, including our expectations for selected financial items for the fourth quarter of 2019.
|
|
·
|
Other Developments in the third quarter of 2019.
|
|
·
|
Results of Operations, containing a year-over-year and sequential analysis of our financial results
for the three and nine months ended September 28, 2019, as well as segment information.
|
|
·
|
Discussion of the impact of changes in exchange rates, interest rates and equity prices on our
activity and financial results.
|
|
·
|
Liquidity and Capital Resources, presenting an analysis of changes in our balance sheets and cash
flows, and discussing our financial condition and potential sources of liquidity.
|
|
·
|
Impact of Recently Issued U.S. Accounting Standards.
|
|
·
|
Backlog and Customers, discussing the level of backlog and sales to our key customers.
|
|
·
|
Disclosure Controls and Procedures.
|
|
·
|
Cautionary Note Regarding Forward-Looking Statements.
|
STMicroelectronics N.V. (“ST”
or the “Company”) is a global semiconductor leader delivering intelligent and energy-efficient products and solutions
that power the electronics at the heart of everyday life. ST’s products are found everywhere today and together with our
customers, we are enabling smarter driving and smarter factories, cities and homes, along with the next generation of mobile and
Internet of Things devices. By getting more from technology to get more from life, ST stands for life.augmented.
Critical Accounting Policies Using Significant
Estimates
There were no material changes in the first
nine months of 2019 to the information provided under the heading “Critical Accounting Policies Using Significant Estimates”
included in our Form 20-F except the new guidance on leasing detailed in Note 5 Recent Accounting Pronouncements.
Fiscal Year
Under Article 35 of our Articles of
Association, our fiscal year extends from January 1 to December 31. The first quarter of 2019 ended on March 30, the
second quarter ended on June 29 and the third quarter ended on September 28. The fourth quarter will end on December 31, 2019.
Based on our fiscal calendar, the distribution of our revenues and expenses by quarter may be unbalanced due to a different number
of days in the various quarters of the fiscal year and can also differ from equivalent prior years’ periods, as illustrated
in the below table for the years 2018 and 2019.
|
Q1
|
Q2
|
Q3
|
Q4
|
|
Days
|
2018
|
90
|
91
|
91
|
93
|
2019
|
89
|
91
|
91
|
94
|
Business Overview
Our results of operations for each period
were as follows:
|
|
Three Months Ended
|
|
% Variation
|
|
|
September 28, 2019
|
|
June 29, 2019
|
|
September 29, 2018
|
|
Sequential
|
|
Year-Over-Year
|
|
|
(In millions, except per share
amounts)
|
|
|
|
|
Net revenues
|
|
$
|
2,553
|
|
|
$
|
2,173
|
|
|
$
|
2,522
|
|
|
|
17.5
|
%
|
|
|
1.2
|
%
|
Gross profit
|
|
|
967
|
|
|
|
830
|
|
|
|
1,003
|
|
|
|
16.4
|
|
|
|
(3.6
|
)
|
Gross margin as percentage of net revenues
|
|
|
37.9
|
%
|
|
|
38.2
|
%
|
|
|
39.8
|
%
|
|
|
-30 bps
|
|
|
|
-190 bps
|
|
Operating income
|
|
|
336
|
|
|
|
196
|
|
|
|
398
|
|
|
|
70.8
|
|
|
|
(15.6
|
)
|
Net income attributable to parent company
|
|
|
302
|
|
|
|
160
|
|
|
|
369
|
|
|
|
88.5
|
|
|
|
(18.3
|
)
|
Earnings per share (Diluted)
|
|
$
|
0.34
|
|
|
$
|
0.18
|
|
|
$
|
0.41
|
|
|
|
88.9
|
%
|
|
|
(17.1
|
)%
|
The total available market is defined as
the “TAM”, while the serviceable available market, the “SAM”, is defined as the market for products sold
by us (which consists of the TAM and excludes major devices such as Microprocessors (MPUs), Dynamic random-access memories (DRAMs),
optoelectronics devices, Flash Memories and the Wireless Application Specific market products such as Baseband and Application
Processor).
Based on the data published by World Semiconductor
Trade Statistics (WSTS), semiconductor industry revenues in the third quarter of 2019 increased sequentially by approximately 8%
for the TAM and 9% for the SAM to reach approximately $107 billion and $51 billion, respectively. On a year-over-year basis, the
TAM decreased by approximately 15% while the SAM increased by approximately 1%.
Third quarter 2019 net revenues amounted
to $2,553 million, increasing sequentially by 17.5% and 220 basis points higher than the mid-point of our released guidance, driven
by engaged customer programs and new products in, as expected, a soft legacy automotive and industrial market. On a sequential
basis, Analog, MEMS and Sensors Group (AMS) revenues increased 39.4% primarily attributable to higher Imaging and Analog revenues.
Microcontrollers and Digital ICs Group (MDG) revenues increased 16.3% due to strong revenue growth in microcontrollers, partially
offset by decrease in digital ICs. Automotive and Discrete Group (ADG) revenues increased 1.1%.
On a year-over-year basis, third quarter
net revenues increased 1.2% mainly driven by higher sales in AMS, partially offset by lower sales in ADG and MDG. AMS revenues
were higher by 7.7%, mainly driven by Imaging and Analog. ADG revenues decreased by 0.8%, mainly due to lower sales in Automotive.
MDG revenues decreased by 4.3% with revenue decrease in both microcontrollers and Digital ICs.
Our revenue performance was above the performance
of the SAM on a sequential basis and in line with the performance of the SAM on year-over-year basis.
Our effective average exchange rate for
the third quarter of 2019 was $1.14 for €1.00, at the same level as the second quarter of 2019 and compared to $1.18 for
€1.00 in the third quarter of 2018. For a more detailed discussion of our hedging arrangements and the impact of fluctuations
in exchange rates, see “Impact of Changes in Exchange Rates”.
Our third quarter of 2019 gross profit
was $967 million and gross margin was 37.9%, 40 basis points above the mid-point of our guidance, mostly due to lower than expected
unused capacity charges in our digital front-end operations associated with higher demand in Imaging. Unused capacity charges impacted
our third quarter gross margin by 110 basis points. On a sequential basis, gross margin decreased 30 basis points, mainly due to
sale price pressure and higher front-end unused capacity charges, partially offset by favorable product mix. Gross margin decreased
190 basis points year-over-year, mainly impacted by sale price pressure and higher front-end unused capacity charges, partially
offset by favorable currency effects, net of hedging and a better product mix.
Our aggregated selling, general & administrative
(SG&A) and research & development (R&D) costs amounted to $629 million, compared to $650 million and $616 million in
the prior and year-ago quarter respectively. The sequential decrease was mainly due to favorable seasonality associated with higher
vacation days. On a year-over-year basis, operating expenses increased mainly due to salary dynamic, increased activity on R&D
programs, partially offset by favorable currency effects, net of hedging.
Other income and expenses, net, amounted
to negative $2 million, decreasing by $20 million sequentially and by $13 million on a year-over-year basis, predominantly impacted
by higher start-up costs associated with the production ramp up of the 8 inch fab recently acquired from Micron Technology Inc.
in Singapore.
In the third quarter of 2019, our operating
income was $336 million, equivalent to 13.1% of net revenues, compared to $196 million in the previous quarter (9.0% of net revenues),
and to $398 million (15.8% of net revenues) in the year-ago quarter. On a sequential basis, the operating income was largely impacted
by higher level of revenues. On a year-over-year basis, operating income was negatively impacted by a combination of sale price
pressure, higher front-end unused capacity charges, increased activity on R&D programs and start-up costs.
Our net cash from operating activities
was $429 million and net cash used in investing activities, excluding the net proceeds from matured marketable securities of $200
million, was $259 million, generating a positive free cash flow (non U.S. GAAP measure) of $170 million for the third quarter of
2019. Our net cash variation was positive $226 million, including the net cash used in financing activities of $129 million (comprised
mainly of the repurchase of common stock of $62 million and dividend payment of $54 million) and the net proceeds from matured
marketable securities of $200 million.
Looking at the fourth quarter, we expect
net revenues to grow approximately 5.0% sequentially at the mid-point, plus or minus 350 basis points, translating into year-over-year
growth of approximately 1.2%. Gross margin is expected to be approximately 38.2%, plus or minus 200 basis points, including about
120 basis points of unsaturation charges. For the full year 2019, we expect net revenues at the mid-point to be about $9.48 billion,
accompanied by a double-digit operating margin performance.
This outlook is based on an assumed
effective currency exchange rate of approximately $1.12 = €1.00 for the 2019 fourth quarter and includes the impact of existing
hedging contracts. The fourth quarter will close on December 31, 2019.
These are forward-looking statements
that are subject to known and unknown risks and uncertainties that could cause actual results to differ materially; in particular,
refer to those known risks and uncertainties described in “Cautionary Note Regarding Forward-Looking Statements” and
Item 3. “Key Information — Risk Factors” in our Form 20-F as may be updated from time to time in our
SEC filings.
Other Developments in the Third Quarter
of 2019
On August 21, we published our IFRS 2019
Semi Annual Accounts for the six-month period ended June 29, 2019 on our website and filed them with the Netherlands Authority
for the Financial Markets (Autoriteit Financiële Markten).
Results of Operations
Segment Information
We design, develop, manufacture and market
a broad range of products, including discrete and standard commodity components, application-specific integrated circuits, full-custom
devices and semi-custom devices and application-specific standard products for analog, digital and mixed-signal applications. In
addition, we further participate in the manufacturing value chain of Smartcard products, which includes the production and sale
of both silicon chips and Smartcards.
Our reportable segments are as follows:
|
·
|
Automotive and Discrete Group (ADG), comprised of dedicated automotive ICs (both digital
and analog), and discrete and power transistor products for all market segments.
|
|
·
|
Analog, MEMS and Sensors Group (AMS), comprised of low-power high-end analog ICs (both custom
and general purpose) for all markets, smart power products for Industrial, Computer and Consumer markets, Touch Screen Controllers,
Low Power Connectivity solutions (both wireline and wireless) for IoT, power conversion products, metering solutions for Smart
Grid and all MEMS products for sensors or actuators, subsystems, as well as the Imaging Products division (including the sensors
and modules utilizing the Company’s Time-of-Flight technology).
|
|
·
|
Microcontrollers and Digital ICs Group (MDG), comprised of general purpose and secure microcontrollers,
EEPROM memories, Digital ASICs, Aerospace & Defense products including components for microwave and millimeter wave.
|
For the computation of the segments’
internal financial measurements, we use certain internal rules of allocation for the costs not directly chargeable to the segments,
including cost of sales, selling, general and administrative expenses and a part of research and development expenses. In compliance
with our internal policies, certain costs are not allocated to the segments, but reported in “Others”. Those include
impairment, restructuring charges and other related closure costs, management reorganization expenses, unused capacity charges,
phase-out and start-up costs of certain manufacturing facilities, certain one-time corporate items, strategic and special research
and development programs or other corporate-sponsored initiatives, including certain corporate-level operating expenses, patent
claims and litigations and certain other miscellaneous charges. In addition, depreciation and amortization expense is part of the
manufacturing costs allocated to the segments and is neither identified as part of the inventory variation nor as part of the unused
capacity charges; therefore, it cannot be isolated in the costs of goods sold. Finally, R&D grants are allocated to the segments
proportionally to the incurred R&D expenses on the sponsored projects.
Wafer costs are allocated to the segments
based on actual cost. From time to time, with respect to specific technologies, wafer costs are allocated to segments based on
market price.
Third Quarter 2019 vs. Second Quarter
2019 and Third Quarter 2018
The following table sets forth certain
financial data from our Unaudited Interim Consolidated Statements of Income:
|
|
Three
Months Ended
|
|
|
September
28, 2019
|
|
June
29, 2019
|
|
September
29, 2018
|
|
|
$
million
|
|
%
of net revenues
|
|
$
million
|
|
%
of net revenues
|
|
$
million
|
|
%
of net revenues
|
Net sales
|
|
$
|
2,547
|
|
|
|
99.8
|
%
|
|
$
|
2,160
|
|
|
|
99.4
|
%
|
|
$
|
2,515
|
|
|
|
99.7
|
%
|
Other revenues
|
|
|
6
|
|
|
|
0.2
|
|
|
|
13
|
|
|
|
0.6
|
|
|
|
7
|
|
|
|
0.3
|
|
Net revenues
|
|
|
2,553
|
|
|
|
100.0
|
|
|
|
2,173
|
|
|
|
100.0
|
|
|
|
2,522
|
|
|
|
100.0
|
|
Cost of sales
|
|
|
(1,586
|
)
|
|
|
(62.1
|
)
|
|
|
(1,343
|
)
|
|
|
(61.8
|
)
|
|
|
(1,519
|
)
|
|
|
(60.2
|
)
|
Gross profit
|
|
|
967
|
|
|
|
37.9
|
|
|
|
830
|
|
|
|
38.2
|
|
|
|
1,003
|
|
|
|
39.8
|
|
Selling, general and administrative
|
|
|
(267
|
)
|
|
|
(10.5
|
)
|
|
|
(269
|
)
|
|
|
(12.4
|
)
|
|
|
(268
|
)
|
|
|
(10.6
|
)
|
Research and development
|
|
|
(362
|
)
|
|
|
(14.2
|
)
|
|
|
(381
|
)
|
|
|
(17.5
|
)
|
|
|
(348
|
)
|
|
|
(13.8
|
)
|
Other income and expenses, net
|
|
|
(2
|
)
|
|
|
(0.1
|
)
|
|
|
18
|
|
|
|
0.8
|
|
|
|
11
|
|
|
|
0.4
|
|
Impairment, restructuring charges and other related closure costs
|
|
|
-
|
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
(0.1
|
)
|
|
|
-
|
|
|
|
-
|
|
Operating income
|
|
|
336
|
|
|
|
13.1
|
|
|
|
196
|
|
|
|
9.0
|
|
|
|
398
|
|
|
|
15.8
|
|
Interest income (expense), net
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
(0.1
|
)
|
Other components of pension benefit costs
|
|
|
(5
|
)
|
|
|
(0.2
|
)
|
|
|
(3
|
)
|
|
|
(0.1
|
)
|
|
|
(3
|
)
|
|
|
(0.1
|
)
|
Income (loss) on equity-method investments
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2
|
|
|
|
0.1
|
|
Income before income taxes and noncontrolling interest
|
|
|
330
|
|
|
|
12.9
|
|
|
|
193
|
|
|
|
8.9
|
|
|
|
395
|
|
|
|
15.7
|
|
Income tax expense
|
|
|
(28
|
)
|
|
|
(1.1
|
)
|
|
|
(33
|
)
|
|
|
(1.5
|
)
|
|
|
(24
|
)
|
|
|
(1.0
|
)
|
Net income
|
|
|
302
|
|
|
|
11.8
|
|
|
|
160
|
|
|
|
7.4
|
|
|
|
371
|
|
|
|
14.7
|
|
Net income attributable to noncontrolling interest
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
(0.1
|
)
|
Net income attributable to parent company
|
|
$
|
302
|
|
|
|
11.8
|
%
|
|
$
|
160
|
|
|
|
7.4
|
%
|
|
$
|
369
|
|
|
|
14.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenues
|
|
Three
Months Ended
|
|
%
Variation
|
|
|
September
28, 2019
|
|
June 29,
2019
|
|
September
29, 2018
|
|
Sequential
|
|
Year-Over
-Year
|
|
|
(In millions)
|
|
|
|
|
Net sales
|
|
$
|
2,547
|
|
|
$
|
2,160
|
|
|
$
|
2,515
|
|
|
|
17.9
|
%
|
|
|
1.3
|
%
|
Other revenues
|
|
|
6
|
|
|
|
13
|
|
|
|
7
|
|
|
|
(53.1
|
)
|
|
|
(13.0
|
)
|
Net revenues
|
|
$
|
2,553
|
|
|
$
|
2,173
|
|
|
$
|
2,522
|
|
|
|
17.5
|
%
|
|
|
1.2
|
%
|
Our third quarter 2019 net revenues increased
sequentially by 17.5%, 220 basis points above the mid-point of our guidance, mainly due to better than expected revenues in Imaging
and microcontrollers only partially offset by lower revenues in automotive legacy products. The sequential increase resulted from
an increase of approximately 16% in volumes and approximately 1% in average selling prices, driven by product mix.
On a year-over-year basis, net revenues
increased by 1.2% as a result of an approximate increase of 3% in average selling prices, entirely due to an improved product mix,
partially offset by an approximate 2% decrease in volumes.
Net revenues by product group
|
|
Three Months Ended
|
|
% Variation
|
|
|
September 28, 2019
|
|
June 29,
2019
|
|
September 29, 2018
|
|
Sequential
|
|
Year-Over
-Year
|
|
|
(In millions)
|
Automotive and Discrete Group (ADG)
|
|
$
|
894
|
|
|
$
|
885
|
|
|
$
|
901
|
|
|
|
1.1
|
%
|
|
|
(0.8
|
)%
|
Analog, MEMS and Sensors Group (AMS)
|
|
|
968
|
|
|
|
694
|
|
|
|
899
|
|
|
|
39.4
|
|
|
|
7.7
|
|
Microcontrollers and Digital ICs Group (MDG)
|
|
|
688
|
|
|
|
591
|
|
|
|
719
|
|
|
|
16.3
|
|
|
|
(4.3
|
)
|
Others
|
|
|
3
|
|
|
|
3
|
|
|
|
3
|
|
|
|
-
|
|
|
|
-
|
|
Total consolidated net revenues
|
|
$
|
2,553
|
|
|
$
|
2,173
|
|
|
$
|
2,522
|
|
|
|
17.5
|
%
|
|
|
1.2
|
%
|
On a sequential basis, third quarter ADG
revenues increased 1.1%. The increase in ADG revenues was driven by an approximate 18% increase in volumes, partially offset by
lower average selling prices of approximately 17%, mainly driven by a less favorable product mix. AMS revenues increased 39.4%
sequentially, mainly due to improved average selling prices of approximately 28%, driven by favorable product mix, and higher volumes
of approximately 11%. MDG revenues increased 16.3%, entirely due to an increase in volumes while average selling prices remained
substantially flat.
On a year-over-year basis, third quarter
net revenues increased by 1.2%, driven by higher revenues in AMS, while ADG and MDG revenues decreased. ADG revenues decreased
0.8% compared to the year-ago period, due to lower average selling prices of approximately 4%, while volumes increased by approximately
3%. AMS revenues increased 7.7% compared to the year-ago period, due to higher average selling prices of approximately 16%, driven
by a more favorable product mix, while volumes decreased by approximately 8%. MDG revenues decreased 4.3% compared to the year-ago
period, due to lower volumes while average selling prices remained substantially flat.
Net Revenues by Market Channel (1)
|
|
Three Months Ended
|
|
|
September 28, 2019
|
|
June 29, 2019
|
|
September 29, 2018
|
|
|
|
|
OEM
|
|
|
|
72
|
%
|
|
|
70
|
%
|
|
|
68
|
%
|
|
Distribution
|
|
|
|
28
|
|
|
|
30
|
|
|
|
32
|
|
|
Total
|
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
____________
|
(1)
|
Original
Equipment Manufacturers (“OEM”) are the end-customers to which we provide direct marketing application engineering
support, while Distribution customers refers to the distributors and representatives that we engage to distribute our products
around the world.
|
By market channel, our third quarter net
revenues in Distribution amounted to 28% of our total revenues, decreasing from 30% and 32% in the prior and year-ago quarters,
respectively.
Net Revenues by Location of Shipment
(1)
|
|
Three Months Ended
|
|
% Variation
|
|
|
September
28, 2019
|
|
June 29,
2019
|
|
September
29, 2018
|
|
Sequential
|
|
Year-Over
-Year
|
|
|
(In millions)
|
EMEA
|
|
$
|
549
|
|
|
$
|
558
|
|
|
$
|
613
|
|
|
|
(1.6
|
)%
|
|
|
(10.5
|
)%
|
Americas
|
|
|
326
|
|
|
|
318
|
|
|
|
315
|
|
|
|
2.5
|
|
|
|
3.4
|
|
Asia Pacific
|
|
|
1,678
|
|
|
|
1,297
|
|
|
|
1,594
|
|
|
|
29.4
|
|
|
|
5.3
|
|
Total
|
|
$
|
2,553
|
|
|
$
|
2,173
|
|
|
$
|
2,522
|
|
|
|
17.5
|
%
|
|
|
1.2
|
%
|
|
(1)
|
Net revenues
by location of shipment are classified by location of customer invoiced or reclassified
by shipment destination in line with customer demand. For example, products ordered by
U.S.-based companies to be invoiced to Asia Pacific affiliates are classified as Asia
Pacific revenues. Furthermore, the comparison among the different periods may be affected
by shifts in shipment from one location to another, as requested by our customers.
|
On a sequential basis, Asia Pacific revenues
increased 29.4%, with Imaging, Analog and Microcontrollers being the main contributors. Americas revenues increased 2.5%, mainly
due to Power and Discrete, and EMEA revenues decreased 1.6%. On a year-over-year basis, Asia Pacific experienced a revenue increase
of 5.3% mainly supported by Imaging and Analog, Americas revenues increased 3.4%, mainly due to Power Discrete, while EMEA revenues
decreased 10.5%, mainly attributable to Automotive, Analog and Microcontrollers.
Gross profit
|
|
Three Months Ended
|
|
Variation
|
|
|
September
28, 2019
|
|
June 29,
2019
|
|
September
29, 2018
|
|
Sequential
|
|
Year-Over
-Year
|
|
|
(In millions)
|
|
|
|
|
Gross profit
|
|
$
|
967
|
|
|
$
|
830
|
|
|
$
|
1,003
|
|
|
|
16.4
|
%
|
|
|
(3.6
|
)%
|
Gross margin (as percentage of net revenues)
|
|
|
37.9
|
%
|
|
|
38.2
|
%
|
|
|
39.8
|
%
|
|
|
-30 bps
|
|
|
|
-190 bps
|
|
In the third quarter of 2019, gross margin
was 37.9%, 40 basis points above the mid-point of our guidance, mostly due to lower unused capacity charges in our digital front-end
operations associated to higher demand in Imaging. On a sequential basis, gross margin decreased 30 basis points, mainly due to
sale price pressure and higher front-end unused capacity charges, partially offset by favorable product mix.
On a year-over-year basis, gross margin
decreased 190 basis points, mainly impacted by sale price pressure and higher front-end unused capacity charges, partially offset
by favorable currency effects, net of hedging and a better product mix.
Operating expenses
|
|
Three Months Ended
|
|
Variation
|
|
|
September
28, 2019
|
|
June 29,
2019
|
|
September
29, 2018
|
|
Sequential
|
|
Year-Over
-Year
|
|
|
(In millions)
|
|
|
|
|
Selling, general and administrative expenses
|
|
$
|
(267
|
)
|
|
$
|
(269
|
)
|
|
$
|
(268
|
)
|
|
|
0.6
|
%
|
|
|
0.2
|
%
|
Research and development expenses
|
|
|
(362
|
)
|
|
|
(381
|
)
|
|
|
(348
|
)
|
|
|
4.9
|
|
|
|
(3.9
|
)
|
Total operating expenses
|
|
$
|
(629
|
)
|
|
$
|
(650
|
)
|
|
$
|
(616
|
)
|
|
|
3.2
|
%
|
|
|
(2.1
|
)%
|
As percentage of net revenues
|
|
|
(24.7
|
)%
|
|
|
(29.9
|
)%
|
|
|
(24.4
|
)%
|
|
|
+520 bps
|
|
|
|
-30 bps
|
|
The third quarter of 2019 operating expenses
were $629 million compared to $650 million in the previous quarter, mainly due to favorable seasonality associated with higher
vacation days. On a year-over-year basis, operating expenses increased by $13 million, mainly due to salary dynamic, increased
activity on R&D programs, partially offset by favorable currency effects, net of hedging.
As a percentage of revenues, our operating
expenses amounted to 24.7% in the third quarter of 2019, decreasing compared to 29.9% in the prior quarter but increasing compared
to 24.4% in the year-ago quarter.
R&D expenses were net of research tax
credits in France and Italy, which amounted to $29 million in the third quarter of 2019, compared to $29 million and $36 million
in the prior and year-ago quarters, respectively.
Other income and expenses, net
|
|
Three Months Ended
|
|
|
September 28,
2019
|
|
June 29,
2019
|
|
September 29,
2018
|
|
|
(In millions)
|
Research and development funding
|
|
$
|
14
|
|
|
$
|
16
|
|
|
$
|
13
|
|
Exchange gain (loss), net
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
1
|
|
Phase-out and start-up costs
|
|
|
(15
|
)
|
|
|
(6
|
)
|
|
|
-
|
|
Patent costs
|
|
|
(1
|
)
|
|
|
1
|
|
|
|
(2
|
)
|
Gain on sale of businesses and non-current assets
|
|
|
-
|
|
|
|
6
|
|
|
|
-
|
|
Other, net
|
|
|
1
|
|
|
|
1
|
|
|
|
(1
|
)
|
Other income and expenses, net
|
|
$
|
(2
|
)
|
|
$
|
18
|
|
|
$
|
11
|
|
As percentage of net revenues
|
|
|
(0.1
|
)%
|
|
|
0.8
|
%
|
|
|
0.4
|
%
|
In the third quarter of 2019, other income
and expenses, net, amounted to negative $2 million, decreasing by $20 million sequentially and by $13 million on a year-over-year
basis, predominantly impacted by higher start-up costs associated with the production ramp up of the 8 inch fab recently acquired
from Micron Technology Inc. in Singapore.
Impairment, restructuring charges
and other related closure costs
|
|
Three Months Ended
|
|
|
September 28, 2019
|
|
June 29, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Impairment, restructuring charges and other related closure costs
|
|
$
|
-
|
|
|
$
|
(2
|
)
|
|
$
|
-
|
|
In the third quarters of 2019 and 2018,
we did not record any impairment, restructuring charges and other related closure costs.
In the second quarter of 2019, we recorded
$2 million of impairment, restructuring charges and other related closure costs, related to the impairment of customized equipment
used for a specific project with no alternative use.
Operating income
|
|
Three Months Ended
|
|
|
September 28, 2019
|
|
June 29, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Operating income
|
|
$
|
336
|
|
|
$
|
196
|
|
|
$
|
398
|
|
As percentage of net revenues
|
|
|
13.1
|
%
|
|
|
9.0
|
%
|
|
|
15.8
|
%
|
The third quarter of 2019 operating income
was $336 million, compared to an operating income of $196 million and $398 million in the prior and year-ago quarters, respectively.
On a sequential basis, operating income
was positively impacted by a higher level of revenues. On a year-over-year basis, operating income was negatively impacted by a
combination of sale price pressure, higher front-end unused capacity charges, increased activity on R&D programs and start-up
costs.
Operating income by product group
|
|
Three Months Ended
|
|
|
September 28, 2019
|
|
June 29, 2019
|
|
September 29, 2018
|
|
|
$ million
|
|
% of net revenues
|
|
$ million
|
|
% of net revenues
|
|
$ million
|
|
% of net revenues
|
Automotive and Discrete Group (ADG)
|
|
$
|
76
|
|
|
|
8.5
|
%
|
|
$
|
73
|
|
|
|
8.2
|
%
|
|
$
|
116
|
|
|
|
12.8
|
%
|
Analog, MEMS and Sensors Group (AMS)
|
|
|
198
|
|
|
|
20.5
|
|
|
|
74
|
|
|
|
10.7
|
|
|
|
157
|
|
|
|
17.5
|
|
Microcontrollers and Digital ICs Group (MDG)
|
|
|
108
|
|
|
|
15.7
|
|
|
|
45
|
|
|
|
7.6
|
|
|
|
119
|
|
|
|
16.6
|
|
Total operating income of product segments
|
|
|
382
|
|
|
|
15.0
|
|
|
|
192
|
|
|
|
8.8
|
|
|
|
392
|
|
|
|
15.6
|
|
Others(1)
|
|
|
(46
|
)
|
|
|
-
|
|
|
|
4
|
|
|
|
-
|
|
|
|
6
|
|
|
|
-
|
|
Total operating income
|
|
$
|
336
|
|
|
|
13.1
|
%
|
|
$
|
196
|
|
|
|
9.0
|
%
|
|
$
|
398
|
|
|
|
15.8
|
%
|
____________
|
(1)
|
Operating
results of “Others” include items such as unused capacity charges, impairment
& restructuring charges and other related closure costs, management reorganization
expenses, phase out and start-up costs, and other unallocated expenses such as strategic
or special research and development programs, certain corporate-level operating expenses,
patent claims and litigations, and other costs that are not allocated to product groups,
as well as assembly services and other revenue.
|
In the third quarter of 2019, ADG operating
income was $76 million, increasing sequentially by $3 million. AMS operating income was $198 million, growing sequentially by $124
million mainly due to improved profitability in Imaging and Analog associated with a higher level of sales. MDG operating income
was $108 million, increasing by $63 million compared to the prior quarter, mainly due to microcontrollers higher sales.
Compared to a year ago, ADG operating income
decreased by $40 million, mainly reflecting lower manufacturing efficiencies. AMS operating income improved by $41 million, driven
by Imaging increased profitability. MDG operating income decreased by $11 million mainly due to microcontrollers lower sales.
Reconciliation to consolidated operating
income
|
|
Three Months Ended
|
|
|
September 28, 2019
|
|
June 29, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Total operating income of product segments
|
|
$
|
382
|
|
|
$
|
192
|
|
|
$
|
392
|
|
Impairment, restructuring charges and other related closure costs
|
|
|
-
|
|
|
|
(2
|
)
|
|
|
-
|
|
Unallocated manufacturing results(1)
|
|
|
(40
|
)
|
|
|
(10
|
)
|
|
|
3
|
|
Strategic and other research and development programs and other non-allocated provisions(2)
|
|
|
(6
|
)
|
|
|
16
|
|
|
|
3
|
|
Total operating income (loss) Others
|
|
|
(46
|
)
|
|
|
4
|
|
|
|
6
|
|
Total consolidated operating income
|
|
$
|
336
|
|
|
$
|
196
|
|
|
$
|
398
|
|
_____________
|
(1)
|
Includes
unallocated unused capacity charges and start-up costs associated with our front-end
manufacturing facilities.
|
|
(2)
|
Includes
unallocated income and expenses such as certain corporate-level operating expenses and
other costs/income that are not allocated to the product segments.
|
Interest income (expense), net
|
|
Three Months Ended
|
|
|
September 28, 2019
|
|
June 29, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Interest income (expense), net
|
|
$
|
(1
|
)
|
|
$
|
-
|
|
|
$
|
(2
|
)
|
In the third quarter of 2019, we recorded
a net interest expense of $1 million, almost flat sequentially and on a year-over-year basis, composed of interest expense on our
borrowings and banking fees of $14 million, partially offset by $13 million of interest income.
Interest expense recorded in the third
and second quarters of 2019, and in the third quarter of 2018, respectively, included a $10 million charge, mainly non-cash, related
to the senior unsecured convertible bonds issued on July 3, 2017.
Income tax expense
|
|
Three Months Ended
|
|
|
September 28, 2019
|
|
June 29, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Income tax expense
|
|
$
|
(28
|
)
|
|
$
|
(33
|
)
|
|
$
|
(24
|
)
|
During the third quarter of 2019, we registered
an income tax expense of $28 million, reflecting the estimated annual effective tax rate in each of our jurisdictions, applied
to the first nine months of 2019 consolidated result before taxes.
In May 2019, Switzerland voted a tax reform
which cancelled all favorable tax regimes and introduced a single tax rate for all companies, which triggered the revaluation of
all deferred tax assets and liabilities. Enactment of this law occurred in third quarter of 2019, which resulted in a tax benefit
of $20 million.
Net income attributable to parent
company
|
|
Three Months Ended
|
|
|
September 28, 2019
|
|
June 29, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Net income attributable to parent company
|
|
$
|
302
|
|
|
$
|
160
|
|
|
$
|
369
|
|
As percentage of net revenues
|
|
|
11.8
|
%
|
|
|
7.4
|
%
|
|
|
14.6
|
%
|
For the third quarter of 2019, we reported
a net income attributable to parent company of $302 million, representing diluted earnings per share of $0.34 compared to
$0.18 in the prior quarter and $0.41 in the prior-year quarter.
First Nine Months of 2019 vs. First
Nine Months of 2018
The following table sets forth consolidated
statements of operations data for the periods indicated:
|
|
Nine Months Ended
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
$ million
|
|
% of net revenues
|
|
$ million
|
|
% of net revenues
|
Net sales
|
|
$
|
6,779
|
|
|
|
99.7
|
%
|
|
$
|
6,978
|
|
|
|
99.5
|
%
|
Other revenues
|
|
|
23
|
|
|
|
0.3
|
|
|
|
38
|
|
|
|
0.5
|
|
Net revenues
|
|
|
6,802
|
|
|
|
100.0
|
|
|
|
7,016
|
|
|
|
100.0
|
|
Cost of sales
|
|
|
(4,187
|
)
|
|
|
(61.6
|
)
|
|
|
(4,214
|
)
|
|
|
(60.1
|
)
|
Gross profit
|
|
|
2,615
|
|
|
|
38.4
|
|
|
|
2,802
|
|
|
|
39.9
|
|
Selling, general and administrative
|
|
|
(808
|
)
|
|
|
(11.9
|
)
|
|
|
(810
|
)
|
|
|
(11.5
|
)
|
Research and development
|
|
|
(1,111
|
)
|
|
|
(16.3
|
)
|
|
|
(1,054
|
)
|
|
|
(15.0
|
)
|
Other income and expenses, net
|
|
|
49
|
|
|
|
0.7
|
|
|
|
38
|
|
|
|
0.5
|
|
Impairment, restructuring charges and other related closure costs
|
|
|
(2
|
)
|
|
|
-
|
|
|
|
(20
|
)
|
|
|
(0.3
|
)
|
Operating income
|
|
|
743
|
|
|
|
10.9
|
|
|
|
956
|
|
|
|
13.6
|
|
Interest income (expense), net
|
|
|
2
|
|
|
|
-
|
|
|
|
(8
|
)
|
|
|
(0.1
|
)
|
Other components of pension benefit costs
|
|
|
(12
|
)
|
|
|
(0.1
|
)
|
|
|
(9
|
)
|
|
|
(0.1
|
)
|
Income (loss) on equity-method investments
|
|
|
1
|
|
|
|
-
|
|
|
|
3
|
|
|
|
-
|
|
Income before income taxes and noncontrolling interest
|
|
|
734
|
|
|
|
10.8
|
|
|
|
942
|
|
|
|
13.4
|
|
Income tax expense
|
|
|
(93
|
)
|
|
|
(1.4
|
)
|
|
|
(68
|
)
|
|
|
(0.9
|
)
|
Net income
|
|
|
641
|
|
|
|
9.4
|
|
|
|
874
|
|
|
|
12.5
|
|
Net loss (income) attributable to noncontrolling interest
|
|
|
(1
|
)
|
|
|
-
|
|
|
|
(5
|
)
|
|
|
(0.1
|
)
|
Net income attributable to parent company
|
|
$
|
640
|
|
|
|
9.4
|
%
|
|
$
|
869
|
|
|
|
12.4
|
%
|
Net revenues
|
|
Nine Months Ended
|
|
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
% Variation
|
|
|
(In millions)
|
|
|
Net sales
|
|
$
|
6,779
|
|
|
$
|
6,978
|
|
|
|
(2.9
|
)%
|
Other revenues
|
|
|
23
|
|
|
|
38
|
|
|
|
(38.1
|
)
|
Net revenues
|
|
$
|
6,802
|
|
|
$
|
7,016
|
|
|
|
(3.1
|
)%
|
Our first nine months 2019 net revenues
decreased by 3.1% compared to the year-ago period as a result of an approximate 10% decrease in volume and an approximate 7% increase
in average selling prices, the latter entirely due to a more favorable product mix.
Net revenues by product group
|
|
Nine Months Ended
|
|
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
% Variation
|
|
|
(In millions)
|
|
|
Automotive and Discrete Group (ADG)
|
|
$
|
2,682
|
|
|
$
|
2,588
|
|
|
|
3.6
|
%
|
Analog, MEMS and Sensors Group (AMS)
|
|
|
2,214
|
|
|
|
2,167
|
|
|
|
2.2
|
|
Microcontrollers and Digital ICs Group (MDG)
|
|
|
1,896
|
|
|
|
2,251
|
|
|
|
(15.8
|
)
|
Others
|
|
|
10
|
|
|
|
10
|
|
|
|
-
|
|
Total consolidated net revenues
|
|
$
|
6,802
|
|
|
$
|
7,016
|
|
|
|
(3.1
|
)%
|
By product group, the first nine months
of 2019 ADG revenues were up 3.6% supported by an average selling price increase of approximately 15%, driven by product mix improvements,
partially compensated by an approximate 11% decrease in volumes. AMS revenues increased 2.2%, due to an approximate 9% increase
in average selling prices, the latter entirely driven by improved product mix, reduced by an approximate 7% decrease in volumes.
MDG revenues decreased 15.8% compared to the prior period, driven by an approximate decrease of 13% in volumes coupled with approximately
3% decrease in average selling prices.
Net Revenues by Market Channel (1)
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
OEM
|
|
|
70
|
%
|
|
|
64
|
%
|
Distribution
|
|
|
30
|
|
|
|
36
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
____________
|
(1)
|
Original
Equipment Manufacturers (“OEM”) are the end-customers to which we provide direct marketing application engineering
support, while Distribution customers refers to the distributors and representatives that we engage to distribute our products
around the world.
|
By market channel, Distribution reached
30% share of total revenues in the first nine months of 2019, compared to approximately 36% in the first nine months of 2018.
Net Revenues by Location of Shipment
(1)
|
|
Nine Months Ended
|
|
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
% Variation
|
|
|
(In millions)
|
|
|
EMEA
|
|
$
|
1,727
|
|
|
$
|
1,861
|
|
|
|
(7.2
|
)%
|
Americas
|
|
|
990
|
|
|
|
922
|
|
|
|
7.4
|
|
Asia Pacific
|
|
|
4,085
|
|
|
|
4,233
|
|
|
|
(3.5
|
)
|
Total
|
|
$
|
6,802
|
|
|
$
|
7,016
|
|
|
|
(3.1
|
)%
|
____________
|
(1)
|
Net revenues
by location of shipment are classified by location of customer invoiced or reclassified
by shipment destination in line with customer demand. For example, products ordered by
U.S.-based companies to be invoiced to Asia Pacific affiliates are classified as Asia
Pacific revenues. Furthermore, the comparison among the different periods may be affected
by shifts in shipment from one location to another, as requested by our customers.
|
By location of shipment, Americas registered
revenue increase of 7.4%, mainly driven by Power Discrete, while EMEA and Asia Pacific revenues decreased by 7.2% and 3.5%, respectively,
mainly due to microcontrollers.
Gross profit
|
|
Nine Months Ended
|
|
|
|
|
September 28, 2019
|
|
% Variation
|
|
|
(In millions)
|
|
|
Gross profit
|
|
$
|
2,615
|
|
|
$
|
2,802
|
|
|
|
(6.7
|
)%
|
Gross margin (as percentage of net revenues)
|
|
|
38.4
|
%
|
|
|
39.9
|
%
|
|
|
-150 bps
|
|
Gross margin was 38.4% for the first nine
months of 2019, decreasing by approximately 150 basis points compared to the year-ago period mainly due to usual sale price pressure
and higher unloading charges.
Operating expenses
|
|
Nine Months Ended
|
|
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
% Variation
|
|
|
(In millions)
|
|
|
Selling, general and administrative expenses
|
|
$
|
(808
|
)
|
|
$
|
(810
|
)
|
|
|
0.2
|
%
|
Research and development expenses
|
|
|
(1,111
|
)
|
|
|
(1,054
|
)
|
|
|
(5.4
|
)
|
Total operating expenses
|
|
$
|
(1,919
|
)
|
|
$
|
(1,864
|
)
|
|
|
(2.9
|
)%
|
As percentage of net revenues
|
|
|
(28.2
|
)%
|
|
|
(26.6
|
)%
|
|
|
-160 bps
|
|
Our operating expenses increased compared
to the year-ago period, negatively impacted by salary dynamic, higher costs of the share based compensation plans and increased
R&D activities, partially offset by the favorable currency effects, net of hedging.
Total R&D expenses were net of research
tax credits, which amounted to $90 million in the first nine months of 2019 and $100 million in the first nine months of 2018.
Other income and expenses, net
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Research and development funding
|
|
$
|
64
|
|
|
$
|
34
|
|
Phase-out and start-up costs
|
|
|
(22
|
)
|
|
|
-
|
|
Exchange gain (loss), net
|
|
|
(1
|
)
|
|
|
4
|
|
Patent costs
|
|
|
(1
|
)
|
|
|
(7
|
)
|
Gain on sale of businesses and non-current assets
|
|
|
6
|
|
|
|
7
|
|
Other, net
|
|
|
3
|
|
|
|
-
|
|
Other income and expenses, net
|
|
$
|
49
|
|
|
$
|
38
|
|
As percentage of net revenues
|
|
|
0.7
|
%
|
|
|
0.5
|
%
|
In the first nine months of 2019, we recognized
other income, net, of $49 million, increasing compared to $38 million in the first nine months of 2018. The increase
is mainly due to higher income from R&D funding, which included a $19 million catch-up from year 2018, associated with Nano
2022 program, partially offset by higher start-up and phase-out costs.
In the first nine months of 2019 we recorded
primarily start-up costs associated with the production ramp up of the 8 inch fab recently acquired from Micron Technology Inc.
in Singapore.
Impairment, restructuring charges
and other related closure costs
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Impairment, restructuring charges and other related closure costs
|
|
$
|
(2
|
)
|
|
$
|
(20
|
)
|
In the first nine months of 2019, we recorded
$2 million of impairment, restructuring charges and other related closure costs, related to the impairment of customized equipment
used for a specific project with no alternative use.
In the first nine months of 2018, we recorded
$20 million of impairment, restructuring charges and other related closure costs, entirely related to the now completed set-top
box restructuring plan.
Operating income
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Operating income
|
|
$
|
743
|
|
|
$
|
956
|
|
As percentage of net revenues
|
|
|
10.9
|
%
|
|
|
13.6
|
%
|
Operating income in the first nine months
of 2019 was $743 million, decreasing by $213 million compared to the prior year period.
Operating
income by product group(1)
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
$ million
|
|
% of net revenues
|
|
$ million
|
|
% of net revenues
|
Automotive and Discrete Group (ADG)
|
|
$
|
244
|
|
|
|
9.1
|
%
|
|
$
|
289
|
|
|
|
11.2
|
%
|
Analog, MEMS and Sensors Group (AMS)
|
|
|
315
|
|
|
|
14.2
|
|
|
|
286
|
|
|
|
13.2
|
|
Microcontrollers and Digital ICs Group (MDG)
|
|
|
235
|
|
|
|
12.4
|
|
|
|
425
|
|
|
|
18.9
|
|
Total operating income of product segments
|
|
|
794
|
|
|
|
11.7
|
|
|
|
1,000
|
|
|
|
14.3
|
|
Others(1)
|
|
|
(51
|
)
|
|
|
-
|
|
|
|
(44
|
)
|
|
|
-
|
|
Total consolidated operating income
|
|
$
|
743
|
|
|
|
10.9
|
%
|
|
$
|
956
|
|
|
|
13.6
|
%
|
____________
|
(1)
|
Operating
results of “Others” include items such as unused capacity charges, impairment
& restructuring charges and other related closure costs, management reorganization
expenses, phase out and start-up costs, and other unallocated expenses such as strategic
or special research and development programs, certain corporate-level operating expenses,
patent claims and litigations, and other costs that are not allocated to product groups,
as well as assembly services and other revenue.
|
In the first nine months of 2019, ADG operating
income decreased by $45 million to $244 million, mainly due to Automotive lower profitability. AMS operating income was $315 million,
increasing by $29 million mainly due to Imaging results. MDG operating income was $235 million and decreased as compared to the
prior quarter by $190 million mainly due to microcontrollers decreased profitability due to lower sales.
Reconciliation to consolidated operating
income (loss)
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Total operating income of product segments
|
|
$
|
794
|
|
|
$
|
1,000
|
|
Impairment, restructuring charges and other related closure costs
|
|
|
(2
|
)
|
|
|
(20
|
)
|
Unallocated manufacturing results(1)
|
|
|
(48
|
)
|
|
|
(2
|
)
|
Strategic and other research and development programs
and other non-allocated
provisions(2)
|
|
|
(1
|
)
|
|
|
(22
|
)
|
Total operating loss Others
|
|
|
(51
|
)
|
|
|
(44
|
)
|
Total consolidated operating income
|
|
$
|
743
|
|
|
$
|
956
|
|
_________________
|
(1)
|
Includes
unallocated unused capacity charges and start-up costs associated with our front-end
manufacturing facilities.
|
|
(2)
|
Includes
unallocated income and expenses such as certain corporate-level operating expenses and
other costs/income that are not allocated to the product segments.
|
Interest income (expense), net
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Interest income (expense), net
|
|
$
|
2
|
|
|
$
|
(8
|
)
|
In the first nine months of 2019, we recorded
a net interest income of $2 million comprised of $43 million of interest income, partially offset by $41 million interest expense
on our borrowings and banking fees, mainly non-cash and related to the senior unsecured convertible bonds issued on July 3, 2017.
In the first nine months of 2018, we recorded
a net interest expense of $8 million, comprised of $40 million interest expense on our borrowings and banking fees, mainly non-cash
and related to the senior unsecured convertible bonds issued on July 3, 2017, partially offset by $32 million of interest income.
Income tax expense
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Income tax expense
|
|
$
|
(93
|
)
|
|
$
|
(68
|
)
|
During the first nine months of 2019, we
registered an income tax expense of $93 million, reflecting the estimated annual effective tax rate in each of our jurisdictions,
applied to the first nine months of 2019 consolidated result before taxes. Our income tax also included the estimated impact of
provisions related to potential tax positions which have been considered uncertain.
In May 2019, Switzerland voted a tax reform
which cancelled all favorable tax regimes and introduced a single tax rate for all companies, which triggered the revaluation of
all deferred tax assets and liabilities. Enactment of this law occurred in third quarter of 2019, which resulted in a tax benefit
of $20 million.
In the first nine months of 2018, we registered
an income tax expense of $68 million.
Our tax rate is variable and depends on
changes in the level of operating results within various local jurisdictions and on changes in the applicable taxation rates of
these jurisdictions, as well as changes in estimations of our tax provisions. Our income tax amounts and rates also depend on our
loss carry-forwards and their relevant valuation allowances, which are based on estimated projected plans and available tax planning
strategies. In the case of material changes in these plans, the valuation allowances could be adjusted accordingly with an impact
on our tax charges. We currently enjoy certain tax benefits in certain countries. Such benefits may not be available in the future
due to changes in the local jurisdictions; our estimated tax rate could be different in future quarters and may increase in the
coming years. In addition, our annual income tax charges include the estimated impact of provisions related to potential tax positions
which have been considered uncertain.
Net income attributable to parent company
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Net income attributable to parent company
|
|
$
|
640
|
|
|
$
|
869
|
|
As percentage of net revenues
|
|
|
9.4
|
%
|
|
|
12.4
|
%
|
For the first nine months of 2019, we reported
net income of $640 million, representing diluted earnings per share of $0.71, compared to a net income of $869 million
in the prior period, representing diluted earnings per share of $0.95.
Legal Proceedings
For a discussion of legal proceedings,
see Note 26 Contingencies, Claims and Legal Proceedings to our Interim Consolidated Financial Statements.
Impact of Changes in Exchange Rates
Our results of operations and financial
condition can be significantly affected by material changes in the exchange rates between the U.S. dollar and other currencies,
particularly the Euro.
As a market practice, the reference currency
for the semiconductor industry is the U.S. dollar and the market prices of semiconductor products are mainly denominated in U.S.
dollars. However, revenues for certain of our products (primarily certain of our products sold in Europe) are quoted in currencies
other than the U.S. dollar and as such are directly affected by fluctuations in the value of the U.S. dollar. As a result of currency
variations, the appreciation of the Euro compared to the U.S. dollar could increase our level of revenues when reported in U.S.
dollars or the depreciation of the Euro compared to the U.S. dollar could decrease our level of revenues when reported in U.S.
dollars. Over time and depending on market conditions, the prices in the industry could align to the equivalent amount in U.S.
dollars, except that there is a lag between the changes in the currency rate and the adjustment in the price paid in local currency,
which is proportional to the amplitude of the currency swing, and such adjustment could be only partial and/or delayed, depending
on market demand. Furthermore, certain significant costs incurred by us, such as manufacturing costs, SG&A expenses, and R&D
expenses, are largely incurred in the currency of the jurisdictions in which our operations are located. Given that most of our
operations are located in the Euro zone and other non-U.S. dollar currency areas, including Singapore, our costs tend to increase
when translated into U.S. dollars when the U.S. dollar weakens or to decrease when the U.S. dollar strengthens.
Our principal strategy to reduce the risks
associated with exchange rate fluctuations has been to balance as much as possible the proportion of sales to our customers denominated
in U.S. dollars with the amount of materials, purchases and services from our suppliers denominated in U.S. dollars, thereby reducing
the potential exchange rate impact of certain variable costs relative to revenues. Moreover, in order to further reduce the exposure
to U.S. dollar exchange fluctuations, we have hedged certain line items on our Interim Consolidated Statements of Income, in particular
with respect to a portion of the costs of sales, most of the R&D expenses and certain SG&A expenses, located in the Euro
zone, which we account for as cash flow hedging contracts. We use two different types of hedging contracts: forward and options
(including collars).
Our Interim Consolidated Statements of
Income for the nine months ended September 28, 2019 included income and expense items translated at the average U.S. dollar
exchange rate for the period, plus the impact of the hedging contracts expiring during the period. Our effective average exchange
rate for the third quarter of 2019 was $1.14 for €1.00, at the same level as the second quarter of 2019 and compared to $1.18
for €1.00 in the third quarter of 2018. These effective exchange rates reflect the actual exchange rates combined with the
impact of cash flow hedging contracts that matured in the period.
The time horizon of our cash flow hedging
for manufacturing costs and operating expenses may run up to 24 months, for a limited percentage of our exposure to the Euro, depending
on currency market circumstances. As of September 28, 2019, the outstanding hedged amounts were €748 million to cover
manufacturing costs and €499 million to cover operating expenses, both at an average exchange rate of approximately $1.17
for €1.00 (considering the collars at upper strike), maturing over the period from October 2, 2019 to January 6, 2021. As
of September 28, 2019, measured with respect to the exchange rate at period closing of approximately $1.09 to €1.00, these
outstanding hedging contracts and certain expiring contracts covering manufacturing expenses capitalized in inventory resulted
in a deferred loss before tax of approximately $42 million, recorded in “Accumulated other comprehensive income (loss)”
in the Consolidated Statements of Equity, compared to a deferred loss before tax of approximately $38 million at December 31,
2018.
We also hedge certain manufacturing costs
denominated in Singapore dollars (SGD); as of September 28, 2019, the outstanding hedged amounts were SGD 165 million at an
average exchange rate of approximately SGD 1.36 to $1.00 maturing over the period from October 3, 2019 to August 27, 2020. As of
September 28, 2019, these outstanding hedging contracts and certain expiring contracts covering manufacturing expenses capitalized
in inventory resulted in a deferred loss before tax of approximately $1 million, recorded in “Accumulated other comprehensive
income (loss)” in the Consolidated Statements of Equity, compared to a deferred loss before tax of approximately $1 million
at December 31, 2018.
Our cash flow hedging policy is not intended
to cover our full exposure and is based on hedging a declining portion of our exposure in the next four quarters. In the third
quarter of 2019, as a result of our cash flow hedging, we recorded a net loss of $17 million consisting of a loss of approximately
$12 million to costs of goods sold, $4 million to research and development and $1 million in selling and administrative expenses,
while in the comparable quarter in 2018, we recorded a net loss of $20 million.
In addition to our cash flow hedging, in
order to mitigate potential exchange rate risks on our commercial transactions, we purchase and enter into forward foreign currency
exchange contracts and currency options to cover foreign currency exposure in payables or receivables at our affiliates, which
we account for as fair value instruments.
We may in the future purchase or sell similar types of instruments. See “Item 11.
Quantitative and Qualitative Disclosures About Market Risk” in our Form 20-F. Furthermore, we may not predict in a timely
fashion the amount of future transactions in the volatile industry environment. No assurance may be given that our hedging activities
will sufficiently protect us against declines in the value of the U.S. dollar. Consequently, our results of operations have been
and may continue to be impacted by fluctuations in exchange rates. The net effect of our consolidated foreign exchange exposure
recorded resulted in a loss of $1 million recorded in “Other income and expenses, net” in our Interim Consolidated
Statements of Income for the third quarter of 2019.
The assets and liabilities of subsidiaries
are, for consolidation purposes, translated into U.S. dollars at the period-end exchange rate. Income and expenses, as well as
cash flows, are translated at the average exchange rate for the period. The balance sheet impact, as well as the income statement
and cash flow impact, of such translations have been, and may be expected to be, significant from period to period since a large
part of our assets and liabilities and activities are accounted for in Euros as they are located in jurisdictions where the Euro
is the functional currency. Adjustments resulting from the translation are recorded directly in equity, and are shown as “Accumulated
other comprehensive income (loss)” in the Consolidated Statements of Equity. At September 28, 2019, our outstanding indebtedness
was denominated mainly in U.S. dollars and in Euros.
For a more detailed discussion, see Item 3.
“Key Information — Risks Related to Our Operations” in our Form 20-F, which may be updated from time to
time in our public filings.
Impact of Changes in Interest Rates
Interest rates may fluctuate upon changes
in financial market conditions and material changes can affect our results of operations and financial condition, since these changes
can impact the total interest income received on our cash and cash equivalents and marketable securities, as well as the total
interest expense paid on our financial debt.
Our interest income (expense), net, as
reported in our Interim Consolidated Statements of Income, is the balance between interest income received from our cash and cash
equivalents and marketable securities investments and interest expense paid on our financial liabilities, non-cash interest expense
on the senior unsecured convertible bonds and bank fees (including fees on committed credit lines). Our interest income is dependent
upon fluctuations in interest rates, mainly in U.S. dollars and Euros, since we invest primarily on a short-term basis; any increase
or decrease in the market interest rates would mean a proportional increase or decrease in our interest income. Our interest expenses
are also dependent upon fluctuations in interest rates, since our financial liabilities include European Investment Bank Floating
Rate Loans at Libor and Euribor plus spreads.
At September 28, 2019, our total financial
resources, including cash and cash equivalents, restricted cash and marketable securities generated an average interest income
annual rate of 2.05%. At the same date, the average interest annual rate on our outstanding debt was 2.28% including the non-cash
effective interest of the senior unsecured convertible bonds issued on July 3, 2017, while the average cash interest annual rate
was only 0.42%.
Impact of Changes in Equity Prices
As of September 28, 2019, we did not hold
any significant equity participations, which could be subject to a material impact in changes in equity prices. However, we hold
equity participations whose carrying value could be reduced due to further losses or impairment charges of our equity-method investments.
See Note 20 to our Consolidated Financial Statements.
Liquidity and Capital Resources
Treasury activities are regulated by our
policies, which define procedures, objectives and controls. Our policies focus on the management of our financial risk in terms
of exposure to currency rates and interest rates. Most treasury activities are centralized, with any local treasury activities
subject to oversight from our head treasury office. The majority of our cash and cash equivalents are held in U.S. dollars and
Euros and are placed with financial institutions rated at least a single A long-term rating, meaning at least A3 from Moody’s
Investors Service (“Moody’s”) and A- from Standard & Poor’s (“S&P”) or Fitch Ratings
(“Fitch”). Marginal amounts are held in other currencies. See “Item 11. Quantitative and Qualitative Disclosures
About Market Risk” in our Form 20-F, which may be updated from time to time in our public filings.
Cash flow
We maintain a significant cash position
and a low debt-to-equity ratio, which provide us with adequate financial flexibility. As in the past, our cash management policy
is to finance our investment needs mainly with net cash generated from operating activities.
During the first nine months of 2019, our
net cash increased by $139 million, due to net cash from operating activities exceeding net cash used in investing and financing
activities.
The components of our cash flow for the
comparable periods are set forth below:
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Net cash from operating activities
|
|
$
|
1,093
|
|
|
$
|
1,189
|
|
Net cash used in investing activities
|
|
|
(857
|
)
|
|
|
(928
|
)
|
Net cash used in financing activities
|
|
|
(79
|
)
|
|
|
(182
|
)
|
Effect of changes in exchange rates
|
|
|
(18
|
)
|
|
|
(3
|
)
|
Net cash increase
|
|
$
|
139
|
|
|
$
|
76
|
|
Net cash from operating activities.
Net cash from operating activities is the sum of (i) net income adjusted for non-cash items and (ii) changes in
net working capital. The net cash from operating activities for the first nine months of 2019 was $1,093 million, decreasing
compared to $1,189 million in the prior-year period mainly due to lower net income.
Net cash used in investing activities.
Investing activities used $857 million of cash in the first nine months of 2019, decreasing compared to $928 million in the
prior-year period. Payments for purchase of tangible assets, net of proceeds, totaled $937 million, compared to $983 million
registered in the prior-year period. The 2019 numbers also included the proceeds from matured marketable securities of $200 million
and the net cash outflow of $76 million for the acquisition of 55% of Norstel’s share capital.
Net cash used in financing activities.
Net cash used in financing activities was $79 million for the first nine months of 2019, compared to $182 million used
for the first nine months of 2018, and consisted mainly of $281 million proceeds from long-term debt, $187 million repurchase of
common stock and $161 million of dividends paid to stockholders.
Free Cash Flow (non U.S. GAAP measure)
We also present Free Cash Flow, which is
a non U.S. GAAP measure, defined as (i) net cash from operating activities plus (ii) net cash used in investing activities, excluding
payment for purchase (and proceeds from matured) marketable securities and short-term deposits. The result of this definition is
ultimately net cash from operating activities plus payment for purchase (and proceeds from sale) of tangible, intangible and financial
assets, proceeds received in the sale of businesses and cash paid for business acquisitions. We believe Free Cash Flow, a non U.S.
GAAP measure, provides useful information for investors and management because it measures our capacity to generate cash from our
operating and investing activities to sustain our operations. Free Cash Flow is not a U.S. GAAP measure and does not represent
total cash flow since it does not include the cash flows generated by or used in financing activities. Free Cash Flow reconciles
with the net cash increase (decrease) by including the payment for purchase (and proceeds from matured) marketable securities and
short-term deposits, the net cash from (used in) financing activities and the effect of changes in exchange rates. In addition,
our definition of Free Cash Flow may differ from definitions used by other companies. Free Cash Flow is determined as follows from
our Consolidated Statements of Cash Flows:
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
September 28, 2019
|
|
September 28, 2019
|
|
September 29, 2018
|
|
|
(In millions)
|
Net cash from operating activities
|
|
$
|
429
|
|
|
$
|
1,093
|
|
|
$
|
1,189
|
|
Net cash used in investing activities
|
|
|
(59
|
)
|
|
|
(857
|
)
|
|
|
(928
|
)
|
Excluding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment for purchase and proceeds from matured marketable securities and short-term deposits
|
|
|
(200
|
)
|
|
|
(200
|
)
|
|
|
(91
|
)
|
Payment for purchase and proceeds from sale of tangible and intangible assets (1)
|
|
|
(259
|
)
|
|
|
(1,057
|
)
|
|
|
(1,019
|
)
|
Free Cash Flow (non U.S. GAAP measure)
|
|
$
|
170
|
|
|
$
|
36
|
|
|
$
|
170
|
|
|
(1)
|
Reflects
the total of the following line items reconciled with our Consolidated Statements of
Cash Flows relating to the investing activities: Payment for purchase of tangible assets,
Proceeds from sale of tangible assets, Payment for purchase of intangible assets, Payment
for purchase of financial assets, Proceeds from sale of financial assets, Proceeds received
in sale of businesses, payment for business acquisition, net of cash and cash equivalents
acquired.
|
Free Cash Flow decreased in the first nine
months of 2019 compared to the year-ago period, mainly due to lower cash from operating activities and the cash outflow of $76
million for the acquisition of 55% of Norstel’s share capital.
Net Financial Position (non U.S. GAAP measure)
Our Net Financial Position represents the
difference between our total financial resources and our total financial debt. Our total financial resources include cash and cash
equivalents, restricted cash, short-term deposits and marketable securities, and our total financial debt includes short-term debt,
including bank overdrafts, and long-term debt, as represented in our Consolidated Balance Sheets. Net Financial Position is not
a U.S. GAAP measure but we believe it provides useful information for investors and management because it gives evidence of our
global position either in terms of net indebtedness or net cash by measuring our capital resources based on cash and cash equivalents,
restricted cash, short-term deposits and marketable securities and the total level of our financial indebtedness. In addition,
our definition of Net Financial Position may differ from definitions used by other companies and therefore comparability may be
limited. Our Net Financial Position for each period has been determined as follows from our Consolidated Balance Sheets:
|
|
As at
|
|
|
September 28, 2019
|
|
December 31, 2018
|
|
September 29, 2018
|
|
|
(In millions)
|
Cash and cash equivalents
|
|
$
|
2,345
|
|
|
$
|
2,266
|
|
|
$
|
1,835
|
|
Short-term deposits
|
|
|
60
|
|
|
|
-
|
|
|
|
8
|
|
Marketable securities
|
|
|
133
|
|
|
|
330
|
|
|
|
328
|
|
Total financial resources
|
|
|
5,538
|
|
|
|
2,596
|
|
|
|
2,171
|
|
Short-term debt
|
|
|
(171
|
)
|
|
|
(146
|
)
|
|
|
(117
|
)
|
Long-term debt
|
|
|
(2,019
|
)
|
|
|
(1,764
|
)
|
|
|
(1,607
|
)
|
Total financial debt
|
|
|
(2,190
|
)
|
|
|
(1,910
|
)
|
|
|
(1,724
|
)
|
Net Financial Position (non U.S. GAAP measure)
|
|
$
|
348
|
|
|
$
|
686
|
|
|
$
|
447
|
|
Our Net Financial Position as of September
28, 2019 was $348 million, decreasing compared to $686 million at December 31, 2018.
Cash and cash equivalents amounted to $2,345
million as at September 28, 2019.
Marketable securities amounted to $133
million as at September 28, 2019 and consisted of U.S. Treasury Bonds available for sale.
Financial debt was $2,190 million
as at September 28, 2019, composed of (i) $171 million of current portion of long-term debt and (ii) $2,019 million
of long-term debt. The breakdown of our total financial debt included (i) $831 million in European Investment Bank (“EIB”)
loans, (ii) $1,344 million in the senior unsecured convertible bonds, and (iii) $15 million in other long-term loans
and loans from other funding programs.
The EIB Loans are comprised of three long-term
amortizing credit facilities as part of our R&D funding programs. The first, signed in 2010, is a €350 million multi-currency
loan to support our industrial and R&D programs. It was drawn mainly in U.S. dollars for an amount of $321 million and only
partially in Euros for an amount of €100 million, of which $108 million remained outstanding as of September 28, 2019. The
second, signed in 2013, is a €350 million multi-currency loan which also supports our R&D programs. It was drawn in U.S.
dollars for an amount of $471 million, of which $176 million is outstanding as of September 28, 2019. The third, signed in August
2017, is a €500 million loan, in relation to R&D and capital expenditure investments in the European Union. It was fully
drawn in Euros corresponding to $547 million outstanding as of September 28, 2019.
On July 3, 2017, we issued a $1.5 billion
offering of senior unsecured bonds convertible into new or existing ordinary shares of ST, for net proceeds of $1,502 million.
The bonds were issued in two $750 million principal amount tranches, one with a maturity of 5 years (37.5% conversion premium,
negative 0.25% yield to maturity, 0% coupon) and the other 7 years (37.5% conversion premium, 0.25% yield to maturity, 0.25% coupon).
The conversion price at issuance was $20.54 on each tranche. The senior unsecured convertible bonds are convertible by the bondholders
or callable by us, following a given time schedule, if certain conditions are satisfied. Under the terms of the bonds, we can satisfy
the conversion rights either in cash or shares, or a combination of the two, at our selection. Assuming the exercise of the Issuer
Soft Call at 130% of the Conversion Price after the initial lock-up period, the underlying shares under net shares settlement will
be 16.9 million. Net proceeds from the issuance of the bonds of $1,502 million were used for general corporate purposes, including
the early redemption of the outstanding $1 billion convertible bonds due 2019 and 2021, completed in the second half of 2017. Upon
initial recognition, the proceeds were allocated between debt and equity by determining the fair value of the liability component
using an income approach.
Our long-term debt contains standard conditions,
but does not impose minimum financial ratios.
At September 28, 2019, debt payments at
redemption value by period were as follows:
|
|
Payments Due by Period
|
|
|
Total
|
|
2019
|
|
2020
|
|
2021
|
|
2022
|
|
2023
|
|
Thereafter
|
|
|
(In millions)
|
Long-term debt (including current portion)
|
|
$2,345
|
|
$
|
142
|
|
|
$
|
171
|
|
|
$
|
117
|
|
|
$
|
808
|
|
|
$
|
57
|
|
|
$
|
1,050
|
|
Our current ratings with the three major
rating agencies that report on us on a solicited basis, are as follows: S&P: “BBB” with stable outlook; Moody’s:
“Baa3” with stable outlook; Fitch: “BBB” with stable outlook.
Financial Outlook: Capital Investment
Our policy is to modulate our capital spending
according to the evolution of the semiconductor market. Based on current market visibility and the combination of new products,
customer demand in the fourth quarter of 2019 and ongoing strategic initiatives, we confirm our capital investment in 2019 in a
range of approximately $1.1 billion to $1.2 billion. A portion of this capital expenditure will be devoted to support three strategic
initiatives: (i) in Agrate, Italy the construction of a new 300mm fab to support next generation mixed signal, IGBT and power products;
(ii) the expansion of the installed capacity in SiC both in front-end and back-end and the start-up of production of GaN technology
in Catania 150mm and Tours 200mm and (iii) next generation Image sensor technology. In addition to our strategic initiatives, our
main capital investment in front-end is in (i) our 300mm fab in Crolles, optimizing existing infrastructure to support production
ramp up on our main runner technologies; (ii) mix evolution, and a few selected programs of capacity growth and infrastructure
preparation, mainly in the area of mixed signal and discrete processes. The most important 2019 capital investment for our back-end
facilities are expected to be: (i) capacity growth on certain package families, including the SiC technology, next generation Imaging
sensor technologies and new products for Automotive and Industrial, to sustain market demand; (ii) modernization and rationalization
of package lines targeting cost savings benefits; and (iii) specific investments in the areas of factory automation, quality, environment
and energy savings. In addition, we will invest in overall capacity adjustment in final testing and wafers probing (EWS) to meet
increased demand and a changed product mix as well as invest in quality, safety, maintenance, productivity and cost savings in
both 150mm, 200mm front-end fabs and back-end plants.
We will continue to invest to support revenues
growth and new products introduction, taking into consideration factors such as trends in the semiconductor industry and capacity
utilization. We expect to need significant financial resources in the coming years for capital expenditures and for our investments
in manufacturing and R&D. We plan to fund our capital requirements from cash provided by operating activities, available funds
and support from third parties, and may have recourse to borrowings under available credit lines and, to the extent necessary
or attractive based on market conditions prevailing at the time, the issuance of debt, convertible bonds or additional equity securities.
A substantial deterioration of our economic results, and consequently of our profitability, could generate a deterioration of the
cash generated by our operating activities. Therefore, there can be no assurance that, in future periods, we will generate the
same level of cash as in prior years to fund our capital expenditure plans for expanding/upgrading our production facilities,
our working capital requirements, our R&D and manufacturing costs.
As a result of our exit from the ST-Ericsson
joint venture, our exposure is limited to covering 50% of ST-Ericsson’s needs to complete the wind-down, which are estimated
to be negligible, based on our current visibility of the ST-Ericsson liquidation balance.
We believe that we have the financial resources
needed to meet our currently projected business requirements for the next twelve months, including capital expenditures for
our manufacturing activities, working capital requirements, approved dividend payments and the repayment of our debts in line with
their maturity dates.
Contractual Obligations, Commercial
Commitments and Contingencies
Our contractual obligations, commercial
commitments and contingencies are mainly comprised of: long term purchase commitments for material, equipment and software license,
take or pay type of agreements to outsource wafers from foundries, commercial agreements with customers, long term debt obligations,
pension obligations and other long term liabilities.
Off-Balance Sheet Arrangements
We had no material off-balance sheet arrangements
at September 28, 2019.
Impact of Recently Issued U.S. Accounting
Standards
See Note 5 Recent Accounting Pronouncements
to our Interim Consolidated Financial Statements.
Backlog and Customers
During the third quarter of 2019, our booking
plus net frames orders decreased compared to the second quarter of 2019. We entered the fourth quarter 2019 with a backlog lower
than the level we had when entering in the third quarter 2019. Backlog (including frame orders) is subject to possible cancellation,
push back and lower ratio of frame orders being translated into firm orders and, thus, it is not necessarily indicative of the
amount of billings or growth to be registered in subsequent periods.
There is no guarantee that any customer
will continue to generate revenues for us at the same levels as in prior periods. If we were to lose one or more of our key customers,
or if they were to significantly reduce their bookings, not confirm planned delivery dates on frame orders in a significant manner
or fail to meet their payment obligations, our operating results and financial condition could be adversely affected.
Disclosure Controls and Procedures
Evaluation
Our management, including the CEO and CFO,
performed an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in
Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934 (“Disclosure Controls”) as of the end of
the period covered by this report. Disclosure Controls are controls and procedures designed to reasonably assure that information
required to be disclosed in our reports filed under the Securities and Exchange Act of 1934, such as this periodic report, is recorded,
processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure Controls are
also designed to reasonably assure that such information is accumulated and communicated to our management, including the CEO and
CFO, as appropriate to allow timely decisions regarding required disclosure. Our quarterly evaluation of Disclosure Controls includes
an evaluation of certain components of our internal control over financial reporting, and internal control over financial reporting
is also separately evaluated on an annual basis.
The evaluation of our Disclosure Controls
included a review of the controls’ objectives and design, our implementation of the controls and their effect on the information
generated for use in this periodic report. In the course of the controls evaluation, we reviewed identified data errors, errors
in process flow or delay in communication, control problems or acts of fraud and sought to confirm that appropriate corrective
actions, including process improvements, were being undertaken. This type of evaluation is performed at least on a quarterly basis
so that the conclusions of management, including the CEO and CFO, concerning the effectiveness of the Disclosure Controls can be
reported in our periodic reports on Form 6-K and Form 20-F. The components of our Disclosure Controls are also evaluated
on an ongoing basis by our Internal Audit Department, which reports directly to our Audit Committee. The overall goals of these
various evaluation activities are to monitor our Disclosure Controls, and to modify them as necessary. Our intent is to maintain
the Disclosure Controls as dynamic systems that change as conditions warrant.
Based upon the controls evaluation, our
CEO and CFO have concluded that, as of the end of the period covered by this periodic report, our Disclosure Controls were effective.
Changes in Internal Control over Financial
Reporting
There were no changes to our internal control
over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably
likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls
No system of internal control over financial
reporting, including one determined to be effective, may prevent or detect all misstatements. It can provide only reasonable assurance
regarding financial statement preparation and presentation. Also, projections of the results of any evaluation of the effectiveness
of internal control over financial reporting into future periods are subject to inherent risk that the relevant controls may become
inadequate due to changes in circumstances or that the degree of compliance with the underlying policies or procedures may deteriorate.
Other Reviews
We have sent this report to our Audit Committee,
which had an opportunity to raise questions with our management and independent auditors before we submitted it to the Securities
and Exchange Commission.
Cautionary Note Regarding Forward-Looking
Statements
Some of the statements contained in this
Form 6-K that are not historical facts, particularly in “Business Overview” and in “Liquidity and Capital
Resources—Financial Outlook: Capital Investment”, are statements of future expectations and other forward-looking statements
(within the meaning of Section 27A of the Securities Act of 1933 or Section 21E of the Securities Exchange Act of 1934,
each as amended) that are based on management’s current views and assumptions, and are conditioned upon and also involve
known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those
anticipated by such statements due to, among other factors:
|
·
|
Changes in global trade policies, including the adoption and expansion of tariffs and trade barriers,
that could affect the macro-economic environment and adversely impact the demand for our products;
|
|
·
|
Uncertain macro-economic and industry trends, which may impact end-market demand for our products;
|
|
·
|
The Brexit vote and the perceptions as to the impact of the withdrawal of the U.K. may adversely
affect business activity, political stability and economic conditions in the U.K., the Eurozone, the EU and elsewhere. While we
do not have material operations in the U.K. and have not experienced any material impact from Brexit on our underlying business
to date, we cannot predict its future implications;
|
|
·
|
Customer demand that differs from projections;
|
|
·
|
The ability to design, manufacture and sell innovative products in a rapidly changing technological
environment;
|
|
·
|
Changes in economic, social, labor, political, or infrastructure conditions in the locations where
we, our customers, or our suppliers operate, including as a result of macro-economic or regional events, military conflicts, social
unrest, labor actions, or terrorist activities;
|
|
·
|
Unanticipated events or circumstances, which may impact our ability to execute our plans and/or
meet the objectives of our R&D and manufacturing programs, which benefit from public funding;
|
|
·
|
Financial difficulties with any of our major distributors or significant curtailment of purchases
by key customers;
|
|
·
|
The loading, product mix, and manufacturing performance of our production facilities and/or our
required volume to fulfill capacity reserved with suppliers or third party manufacturing providers;
|
|
·
|
Availability and costs of equipment, raw materials, utilities, third-party manufacturing services
and technology, or other supplies required by our operations;
|
|
·
|
The functionalities and performance of our IT systems, which are subject to cybersecurity threats
and which support our critical operational activities including manufacturing, finance and sales, and any breaches of our IT systems
or those of our customers or suppliers;
|
|
·
|
Theft, loss, or misuse of personal data about our employees, customers, or other third parties,
and breaches of global and local privacy legislation, including the EU’s General Data Protection Regulation (“GDPR”);
|
|
·
|
The impact of intellectual property (“IP”) claims by our competitors or other third
parties, and our ability to obtain required licenses on reasonable terms and conditions;
|
|
·
|
Changes in our overall tax position as a result of changes in tax rules, new or revised legislation,
the outcome of tax audits or changes in international tax treaties which may impact our results of operations as well as our ability
to accurately estimate tax credits, benefits, deductions and provisions and to realize deferred tax assets;
|
|
·
|
Variations in the foreign exchange markets and, more particularly, the U.S. dollar exchange rate
as compared to the Euro and the other major currencies we use for our operations;
|
|
·
|
The outcome of ongoing litigation as well as the impact of any new litigation to which we may become
a defendant;
|
|
·
|
Product liability or warranty claims, claims based on epidemic or delivery failure, or other claims
relating to our products, or recalls by our customers for products containing our parts;
|
|
·
|
Natural events such as severe weather, earthquakes, tsunamis, volcano eruptions or other acts of
nature, health risks and epidemics in locations where we, our customers or our suppliers operate;
|
|
·
|
Industry changes resulting from vertical and horizontal consolidation among our suppliers, competitors,
and customers; and
|
|
·
|
The ability to successfully ramp up new programs that could be impacted by factors beyond our control,
including the availability of critical third party components and performance of subcontractors in line with our expectations.
|
Such forward-looking statements are subject
to various risks and uncertainties, which may cause actual results and performance of our business to differ materially and adversely
from the forward-looking statements. Certain forward-looking statements can be identified by the use of forward-looking terminology,
such as “believes”, “expects”, “may”, “are expected to”, “should”,
“would be”, “seeks” or “anticipates” or similar expressions or the negative thereof or other
variations thereof or comparable terminology, or by discussions of strategy, plans or intentions.
Some of these risk factors are
set forth and are discussed in more detail in “Item 3. Key Information” in our Form 20-F. Should one or more
of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially
from those described in our Form 20-F as anticipated, believed or expected. We do not intend, and do not assume any obligation,
to update any industry information or forward-looking statements set forth in this Form 6-K to reflect subsequent events or
circumstances.
Unfavorable changes in the above or other
factors listed under “Item 3. Key Information” from time to time in our SEC filings, could have a material adverse
effect on our business and/or financial condition.
STMICROELECTRONICS N.V.
UNAUDITED INTERIM CONSOLIDATED FINANCIAL
STATEMENTS
|
Pages
|
Consolidated Statements of Income for the Three and Nine Months Ended September 28, 2019 and September 29, 2018 (unaudited)
|
F-1
|
Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 28, 2019 and September 29, 2018 (unaudited)
|
F-3
|
Consolidated Balance Sheets as of September 28, 2019 (unaudited) and December 31, 2018 (audited)
|
F-5
|
Consolidated Statements of Cash Flows for the Nine Months Ended September 28, 2019 and September 29, 2018 (unaudited)
|
F-6
|
Consolidated Statements of Equity (unaudited)
|
F-7
|
Notes to Interim Consolidated Financial Statements (unaudited)
|
F-8
|
STMicroelectronics N.V.
|
|
|
|
|
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
Nine months ended
|
|
|
(Unaudited)
|
|
|
September 28,
|
|
September 29,
|
In million of U.S. dollars except per share amounts
|
|
2019
|
|
2018
|
|
|
|
|
|
Net sales
|
|
|
6,779
|
|
|
|
6,978
|
|
Other revenues
|
|
|
23
|
|
|
|
38
|
|
Net revenues
|
|
|
6,802
|
|
|
|
7,016
|
|
Cost of sales
|
|
|
(4,187
|
)
|
|
|
(4,214
|
)
|
Gross profit
|
|
|
2,615
|
|
|
|
2,802
|
|
Selling, general and administrative
|
|
|
(808
|
)
|
|
|
(810
|
)
|
Research and development
|
|
|
(1,111
|
)
|
|
|
(1,054
|
)
|
Other income and expenses, net
|
|
|
49
|
|
|
|
38
|
|
Impairment, restructuring charges and other related closure costs
|
|
|
(2
|
)
|
|
|
(20
|
)
|
Operating income
|
|
|
743
|
|
|
|
956
|
|
Interest income (expense), net
|
|
|
2
|
|
|
|
(8
|
)
|
Other components of pension benefit costs
|
|
|
(12
|
)
|
|
|
(9
|
)
|
Income (loss) on equity-method investments
|
|
|
1
|
|
|
|
3
|
|
Income before income taxes and noncontrolling interest
|
|
|
734
|
|
|
|
942
|
|
Income tax expense
|
|
|
(93
|
)
|
|
|
(68
|
)
|
Net income
|
|
|
641
|
|
|
|
874
|
|
Net income attributable to noncontrolling interest
|
|
|
(1
|
)
|
|
|
(5
|
)
|
Net income attributable to parent company
|
|
|
640
|
|
|
|
869
|
|
|
|
|
|
|
|
|
|
|
Earnings per share (Basic) attributable to parent company stockholders
|
|
|
0.71
|
|
|
|
0.97
|
|
Earnings per share (Diluted) attributable to parent company stockholders
|
|
|
0.71
|
|
|
|
0.95
|
|
The accompanying notes are an integral part of these unaudited interim consolidated financial statements
STMicroelectronics N.V.
|
|
|
|
|
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
|
(Unaudited)
|
|
|
September 28,
|
|
September 29,
|
In million of U.S. dollars except per share amounts
|
|
2019
|
|
2018
|
|
|
|
|
|
Net sales
|
|
|
2,547
|
|
|
|
2,515
|
|
Other revenues
|
|
|
6
|
|
|
|
7
|
|
Net revenues
|
|
|
2,553
|
|
|
|
2,522
|
|
Cost of sales
|
|
|
(1,586
|
)
|
|
|
(1,519
|
)
|
Gross profit
|
|
|
967
|
|
|
|
1,003
|
|
Selling, general and administrative
|
|
|
(267
|
)
|
|
|
(268
|
)
|
Research and development
|
|
|
(362
|
)
|
|
|
(348
|
)
|
Other income and expenses, net
|
|
|
(2
|
)
|
|
|
11
|
|
Impairment, restructuring charges and other related closure costs
|
|
|
-
|
|
|
|
-
|
|
Operating income
|
|
|
336
|
|
|
|
398
|
|
Interest expense, net
|
|
|
(1
|
)
|
|
|
(2
|
)
|
Other components of pension benefit costs
|
|
|
(5
|
)
|
|
|
(3
|
)
|
Income (loss) on equity-method investments
|
|
|
-
|
|
|
|
2
|
|
Income before income taxes and noncontrolling interest
|
|
|
330
|
|
|
|
395
|
|
Income tax expense
|
|
|
(28
|
)
|
|
|
(24
|
)
|
Net income
|
|
|
302
|
|
|
|
371
|
|
Net income attributable to noncontrolling interest
|
|
|
-
|
|
|
|
(2
|
)
|
Net income attributable to parent company
|
|
|
302
|
|
|
|
369
|
|
|
|
|
|
|
|
|
|
|
Earnings per share (Basic) attributable to parent company stockholders
|
|
|
0.34
|
|
|
|
0.41
|
|
Earnings per share (Diluted) attributable to parent company stockholders
|
|
|
0.34
|
|
|
|
0.41
|
|
The accompanying notes are an integral part of these unaudited interim consolidated financial statements
STMicroelectronics N.V.
|
|
|
|
|
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|
|
|
|
|
|
|
|
Nine months ended
|
|
|
(Unaudited)
|
|
|
September 28,
|
|
September 29,
|
In million of U.S. dollars
|
|
2019
|
|
2018
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
641
|
|
|
|
874
|
|
Other comprehensive income (loss), net of tax :
|
|
|
|
|
|
|
|
|
Currency translation adjustments arising during the period
|
|
|
(89
|
)
|
|
|
(68
|
)
|
Foreign currency translation adjustments
|
|
|
(89
|
)
|
|
|
(68
|
)
|
Net unrealized gains (losses) arising during the period
|
|
|
3
|
|
|
|
(4
|
)
|
Net unrealized gains (losses) on securities
|
|
|
3
|
|
|
|
(4
|
)
|
Net unrealized gains (losses) arising during the period
|
|
|
(59
|
)
|
|
|
(62
|
)
|
Less : reclassification adjustment for (income) losses included in net income
|
|
|
55
|
|
|
|
(26
|
)
|
Net unrealized gains (losses) on derivatives
|
|
|
(4
|
)
|
|
|
(88
|
)
|
Net gains (losses) arising during the period
|
|
|
3
|
|
|
|
6
|
|
Defined benefit pension plans
|
|
|
3
|
|
|
|
6
|
|
Other comprehensive income (loss), net of tax
|
|
|
(87
|
)
|
|
|
(154
|
)
|
Comprehensive income (loss)
|
|
|
554
|
|
|
|
720
|
|
Less : comprehensive income (loss) attributable to noncontrolling interest
|
|
|
1
|
|
|
|
5
|
|
Comprehensive income (loss) attributable to the company's stockholders
|
|
|
553
|
|
|
|
715
|
|
The accompanying notes are an integral part of these unaudited interim consolidated financial statements
STMicroelectronics N.V.
|
|
|
|
|
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|
|
|
|
|
|
|
|
Three months ended
|
|
|
(Unaudited)
|
|
|
September 28,
|
|
September 29,
|
In million of U.S. dollars
|
|
2019
|
|
2018
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
302
|
|
|
|
371
|
|
Other comprehensive income (loss), net of tax :
|
|
|
|
|
|
|
|
|
Currency translation adjustments arising during the period
|
|
|
(77
|
)
|
|
|
(13
|
)
|
Foreign currency translation adjustments
|
|
|
(77
|
)
|
|
|
(13
|
)
|
Net unrealized gains (losses) arising during the period
|
|
|
-
|
|
|
|
-
|
|
Net unrealized gains (losses) on securities
|
|
|
-
|
|
|
|
-
|
|
Net unrealized gains (losses) arising during the period
|
|
|
(39
|
)
|
|
|
(13
|
)
|
Less : reclassification adjustment for (income) losses included in net income
|
|
|
14
|
|
|
|
20
|
|
Net unrealized gains (losses) on derivatives
|
|
|
(25
|
)
|
|
|
7
|
|
Net gains (losses) arising during the period
|
|
|
(1
|
)
|
|
|
2
|
|
Defined benefit pension plans
|
|
|
(1
|
)
|
|
|
2
|
|
Other comprehensive income (loss), net of tax
|
|
|
(103
|
)
|
|
|
(4
|
)
|
Comprehensive income (loss)
|
|
|
199
|
|
|
|
367
|
|
Less : comprehensive income (loss) attributable to noncontrolling interest
|
|
|
-
|
|
|
|
2
|
|
Comprehensive income (loss) attributable to the company's stockholders
|
|
|
199
|
|
|
|
365
|
|
The accompanying notes are an integral part of these unaudited interim consolidated financial statements
STMicroelectronics N.V.
|
|
|
|
|
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
As at
|
|
|
|
|
|
|
|
|
September 28,
|
|
|
|
December 31,
|
|
In million of U.S. dollars
|
|
|
2019
|
|
|
|
2018
|
|
|
|
|
(Unaudited)
|
|
|
|
(Audited)
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
Current assets :
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
2,345
|
|
|
|
2,266
|
|
Restricted cash
|
|
|
60
|
|
|
|
-
|
|
Marketable securities
|
|
|
133
|
|
|
|
330
|
|
Trade accounts receivable, net
|
|
|
1,388
|
|
|
|
1,277
|
|
Inventories
|
|
|
1,785
|
|
|
|
1,562
|
|
Other current assets
|
|
|
415
|
|
|
|
419
|
|
Total current assets
|
|
|
6,126
|
|
|
|
5,854
|
|
Goodwill
|
|
|
161
|
|
|
|
121
|
|
Other intangible assets, net
|
|
|
291
|
|
|
|
212
|
|
Property, plant and equipment, net
|
|
|
3,897
|
|
|
|
3,495
|
|
Non-current deferred tax assets
|
|
|
684
|
|
|
|
672
|
|
Long-term investments
|
|
|
62
|
|
|
|
61
|
|
Other non-current assets
|
|
|
401
|
|
|
|
452
|
|
|
|
|
5,496
|
|
|
|
5,013
|
|
Total assets
|
|
|
11,622
|
|
|
|
10,867
|
|
|
|
|
|
|
|
|
|
|
Liabilities and equity
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Short-term debt
|
|
|
171
|
|
|
|
146
|
|
Trade accounts payable
|
|
|
915
|
|
|
|
981
|
|
Other payables and accrued liabilities
|
|
|
857
|
|
|
|
874
|
|
Dividends payable to stockholders
|
|
|
112
|
|
|
|
60
|
|
Accrued income tax
|
|
|
77
|
|
|
|
59
|
|
Total current liabilities
|
|
|
2,132
|
|
|
|
2,120
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
2,019
|
|
|
|
1,764
|
|
Post-employment benefit obligations
|
|
|
386
|
|
|
|
385
|
|
Long-term deferred tax liabilities
|
|
|
18
|
|
|
|
14
|
|
Other long-term liabilities
|
|
|
315
|
|
|
|
160
|
|
|
|
|
2,738
|
|
|
|
2,323
|
|
Total liabilities
|
|
|
4,870
|
|
|
|
4,443
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
|
|
Parent company stockholders' equity
|
|
|
|
|
|
|
|
|
Common stock (preferred stock: 540,000,000 shares authorized, not issued; common stock: Euro 1.04 par value, 1,200,000,000 shares authorized, 911,181,920 shares issued, 894,103,449 shares outstanding)
|
|
|
1,157
|
|
|
|
1,157
|
|
Capital surplus
|
|
|
2,950
|
|
|
|
2,843
|
|
Retained earnings
|
|
|
2,355
|
|
|
|
1,991
|
|
Accumulated other comprehensive income
|
|
|
422
|
|
|
|
509
|
|
Treasury stock
|
|
|
(266
|
)
|
|
|
(141
|
)
|
Total parent company stockholders' equity
|
|
|
6,618
|
|
|
|
6,359
|
|
Noncontrolling interest
|
|
|
134
|
|
|
|
65
|
|
Total equity
|
|
|
6,752
|
|
|
|
6,424
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and equity
|
|
|
11,622
|
|
|
|
10,867
|
|
The accompanying notes are an integral
part of these unaudited interim consolidated financial statements
STMicroelectronics N.V.
|
|
|
|
|
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
(Unaudited)
|
|
(Unaudited)
|
|
|
September 28,
|
|
September 29,
|
In million of U.S. dollars
|
|
2019
|
|
2018
|
|
|
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
Net income
|
|
|
641
|
|
|
|
874
|
|
Items to reconcile net income and cash flows from operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
634
|
|
|
|
579
|
|
Interests and amortization of issuance costs on convertible bonds
|
|
|
28
|
|
|
|
28
|
|
Non-cash stock-based compensation
|
|
|
107
|
|
|
|
80
|
|
Other non-cash items
|
|
|
(82
|
)
|
|
|
(85
|
)
|
Deferred income tax
|
|
|
9
|
|
|
|
21
|
|
Loss (income) on equity-method investments
|
|
|
(1
|
)
|
|
|
(3
|
)
|
Impairment, restructuring charges and other related closure costs, net of cash payments
|
|
|
(15
|
)
|
|
|
(8
|
)
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
Trade receivables, net
|
|
|
(111
|
)
|
|
|
(180
|
)
|
Inventories
|
|
|
(254
|
)
|
|
|
(272
|
)
|
Trade payables
|
|
|
11
|
|
|
|
68
|
|
Other assets and liabilities, net
|
|
|
126
|
|
|
|
87
|
|
Net cash from operating activities
|
|
|
1,093
|
|
|
|
1,189
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
Payment for purchase of tangible assets
|
|
|
(944
|
)
|
|
|
(984
|
)
|
Proceeds from sale of tangible assets
|
|
|
7
|
|
|
|
1
|
|
Proceeds from matured marketable securities
|
|
|
200
|
|
|
|
100
|
|
Investment in short-term deposits
|
|
|
-
|
|
|
|
(26
|
)
|
Proceeds from matured short-term deposits
|
|
|
-
|
|
|
|
17
|
|
Payment for purchase of intangible assets
|
|
|
(42
|
)
|
|
|
(36
|
)
|
Payment for purchase of financial assets
|
|
|
(2
|
)
|
|
|
-
|
|
Payment for business acquisitions, net of cash and cash equivalents acquired
|
|
|
(76
|
)
|
|
|
-
|
|
Net cash used in investing activities
|
|
|
(857
|
)
|
|
|
(928
|
)
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from long-term debt
|
|
|
281
|
|
|
|
-
|
|
Repayment of long-term debt
|
|
|
(2
|
)
|
|
|
(2
|
)
|
Repurchase of common stock
|
|
|
(187
|
)
|
|
|
-
|
|
Dividends paid to stockholders
|
|
|
(161
|
)
|
|
|
(162
|
)
|
Proceeds from noncontrolling interests
|
|
|
7
|
|
|
|
-
|
|
Payment of withholding tax on vested shares
|
|
|
(17
|
)
|
|
|
(18
|
)
|
Net cash used in financing activities
|
|
|
(79
|
)
|
|
|
(182
|
)
|
Effect of changes in exchange rates
|
|
|
(18
|
)
|
|
|
(3
|
)
|
Net cash increase
|
|
|
139
|
|
|
|
76
|
|
Cash, cash equivalents and restricted cash at beginning of the period
|
|
|
2,266
|
|
|
|
1,759
|
|
Cash, cash equivalents and restricted cash at end of the period
|
|
|
2,405
|
|
|
|
1,835
|
|
The accompanying notes are an integral
part of these unaudited interim consolidated financial statements
STMicroelectronics N.V.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENTS OF EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In million of U.S. dollars, except per share amounts
|
|
|
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other
|
|
|
|
|
|
|
Common
|
|
Capital
|
|
Treasury
|
|
Retained
|
|
Comprehensive
|
|
Noncontrolling
|
|
Total
|
|
|
Stock
|
|
Surplus
|
|
Stock
|
|
Earnings
|
|
Income (Loss)
|
|
Interest
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2017 (Audited)
|
|
|
1,157
|
|
|
|
2,718
|
|
|
|
(132
|
)
|
|
|
973
|
|
|
|
688
|
|
|
|
63
|
|
|
|
5,467
|
|
Repurchase of common stock
|
|
|
|
|
|
|
|
|
|
|
(62
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(62
|
)
|
Stock-based compensation expense
|
|
|
|
|
|
|
125
|
|
|
|
53
|
|
|
|
(53
|
)
|
|
|
|
|
|
|
|
|
|
|
125
|
|
Comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,287
|
|
|
|
|
|
|
|
6
|
|
|
|
1,293
|
|
Other comprehensive income (loss), net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(179
|
)
|
|
|
|
|
|
|
(179
|
)
|
Comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,114
|
|
Dividends to noncontrolling interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4
|
)
|
|
|
(4
|
)
|
Dividends, $0.24 per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(216
|
)
|
|
|
|
|
|
|
|
|
|
|
(216
|
)
|
Balance as of December 31, 2018 (Audited)
|
|
|
1,157
|
|
|
|
2,843
|
|
|
|
(141
|
)
|
|
|
1,991
|
|
|
|
509
|
|
|
|
65
|
|
|
|
6,424
|
|
Contribution of noncontrolling interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7
|
|
|
|
7
|
|
Business combination
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
61
|
|
|
|
61
|
|
Repurchase of common stock
|
|
|
|
|
|
|
|
|
|
|
(187
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(187
|
)
|
Stock-based compensation expense
|
|
|
|
|
|
|
107
|
|
|
|
62
|
|
|
|
(62
|
)
|
|
|
|
|
|
|
|
|
|
|
107
|
|
Comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
640
|
|
|
|
|
|
|
|
1
|
|
|
|
641
|
|
Other comprehensive income (loss), net of tax
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(87
|
)
|
|
|
|
|
|
|
(87
|
)
|
Comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
554
|
|
Dividends, $0.24 per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(214
|
)
|
|
|
|
|
|
|
|
|
|
|
(214
|
)
|
Balance as of September 28, 2019 (Unaudited)
|
|
|
1,157
|
|
|
|
2,950
|
|
|
|
(266
|
)
|
|
|
2,355
|
|
|
|
422
|
|
|
|
134
|
|
|
|
6,752
|
|
The accompanying notes are an integral
part of these unaudited interim consolidated financial statements
STMicroelectronics N.V.
Notes to Interim Consolidated Financial
Statements (Unaudited)
STMicroelectronics N.V. (the “Company”)
is registered in The Netherlands with its corporate legal seat in Amsterdam, the Netherlands, and its corporate headquarters located
in Geneva, Switzerland.
The Company is a global independent semiconductor
company that designs, develops, manufactures and markets a broad range of products, including discrete and standard commodity components,
application-specific integrated circuits (“ASICs”), full custom devices and semi-custom devices and application-specific
standard products (“ASSPs”) for analog, digital and mixed-signal applications. In addition, the Company participates
in the manufacturing value chain of smartcard products, which includes the production and sale of both silicon chips and smartcards.
The Company’s fiscal year ends on
December 31. Interim periods are established for accounting purposes on a thirteen-week basis.
The Company’s third quarter ended
on September 28 and its fourth quarter will end on December 31.
The accompanying Unaudited Interim Consolidated
Financial Statements of the Company have been prepared in conformity with accounting principles generally accepted in the United
States of America (“U.S. GAAP”), consistent in all material respects with those applied for the year ended December
31, 2018, except for the effects of adopting new accounting guidance effective on January 1, 2019, as described in Note 5. The
interim financial information is unaudited but reflects all normal adjustments which are, in the opinion of management, necessary
to provide a fair statement of results for the periods presented. The results of operations for the interim period are not necessarily
indicative of the results to be expected for the entire year.
All balances and values in the current
and prior periods are in millions of U.S. dollars, except shares and per-share amounts.
The accompanying Unaudited Interim Consolidated
Financial Statements do not include certain footnotes and financial presentation normally required on an annual basis under U.S.
GAAP. Therefore, these interim financial statements should be read in conjunction with the Consolidated Financial Statements in
the Company’s Annual Report on Form 20-F for the year ended December 31, 2018, as filed with the U.S. Securities and
Exchange Commission (the “SEC”) on February 28, 2019. However, they include mandatory disclosures required by accounting
pronouncements effective on January 1, 2019, as further described in Note 5.
The preparation of financial statements
in accordance with U.S. GAAP requires management to make estimates and assumptions. The primary areas that require significant
estimates and judgments by management include, but are not limited to:
|
•
|
sales returns and allowances,
|
|
•
|
inventory obsolescence reserves and normal manufacturing capacity thresholds to determine costs
capitalized in inventory,
|
|
•
|
recognition and measurement of loss contingencies,
|
|
•
|
valuation at fair value of assets acquired or sold, including intangibles, goodwill, investments
and tangible assets,
|
|
•
|
measurement of right-of-use assets and financial liabilities related to the accounting for lease
arrangements,
|
|
•
|
annual and trigger-based impairment review of goodwill and intangible assets, as well as the assessment,
in each reporting period, of events, which could trigger impairment testing on long-lived assets,
|
|
•
|
assessment of other-than-temporary impairment charges on financial assets, including equity-method
investments,
|
|
•
|
recognition and measurement of restructuring charges and other related exit costs,
|
|
•
|
assumptions used in assessing the number of awards expected to vest on stock-based compensation
plans,
|
|
•
|
assumptions used in calculating pension obligations and other long-term employee benefits, and
|
|
•
|
determination of the income tax expense estimated on the basis of the projected tax amount for
the full year, including deferred income tax assets, valuation allowance and provisions for uncertain tax positions and claims.
|
The Company bases the estimates and assumptions
on historical experience and on various other factors such as market trends, market information used by market participants and
the latest available business plans that it believes to be reasonable under the circumstances, the results of which form the basis
for making judgments about the carrying values of assets and liabilities. While the Company regularly evaluates its estimates and
assumptions, the actual results experienced by the Company could differ materially and adversely from those estimates.
|
5.
|
Recent Accounting Pronouncements
|
Accounting pronouncements
effective in 2019
Lease accounting
The Company adopted on January 1, 2019
ASC 842 guidance on lease accounting by applying the optional simplified transition method with cumulative impact recorded in retained
earnings at January 1, 2019 and no restatement of previous periods. In compliance with the new lease accounting guidance, as a
lessee, the Company recognizes lease arrangements on the balance sheet as right-of-use assets as a category within “Property,
plant and equipment, net”. The corresponding lease liabilities are reported on the line “Other long-term liabilities”
when payment is expected beyond twelve months, and on the line “Other payables and accrued liabilities” for the current
portion of the lease obligations. For income statement purposes, the new guidance is still based on a dual model, requiring leases
to be classified as either operating or finance leases. Classification criteria are largely similar to current lease accounting
guidance, except that the new guidance does not contain explicit bright lines. The new guidance has not changed the way operating
lease expenses are recognized in the consolidated income statements, which is recorded on a straight-line basis over the lease
period and reported as “Cost of sales”, “Selling, general and administrative”, or “Research and development”
in the consolidated statements of income according to the intended use of the leased asset.
Lessor accounting is similar to the previously
applied model, but updated to align with certain changes to the lessee model and the new revenue recognition guidance. Existing
sale-leaseback guidance has been replaced with a new model applicable to both lessees and lessors. The Company did not report any
existing sale-leaseback transaction upon adoption. Moreover, the Company is not involved in any significant lease arrangement in
which it acts as a lessor.
Prior to the new guidance adoption, the
Company classified as capital leases arrangements in which the Company had substantially all the risks and rewards of owernship.
Only assets leased under capital leases were included in “Property, plant and equipment, net” and recorded at the lower
of their fair value and the present value of the minimum lease payments. The Company did not report any material capital lease
arrangement as at December 31, 2018.
The Company elected the package of transition
practical expedients, which allowed the Company not to (1) reassess whether any expired or existing contracts are or contain leases,
(2) reassess the lease classification for any expired or existing leases and (3) reassess initial direct costs for any existing
leases. Additionally, the Company has elected not to allocate the consideration in existing contracts between lease and nonlease
components.
The Company also elected to exclude from
capitalization lease arrangements with a total duration lower than twelve months and amounts below $5,000. The impact upon adoption
was an increase of property, plant and equipment to reflect the right-of-use assets for the existing lease arrangements, with a
corresponding increase in other payables and accrued liabilities, for the operating lease obligations which payment is expected
within one year, and other long-term liabilities for obligations with payments beyond one year. The value of capitalized lease
arrangements totaled $204 million as of September 28, 2019, which is further described in Note 19.
Hedge accounting
The Company adopted on January 1, 2019
the improvements to hedge accounting issued in August 2017. The changes to existing guidance are intended to align hedge accounting
with companies’ risk management strategies by simplifying the application of hedge accounting and enlarging the scope and
results of hedging programs. The amendments to the existing guidance include designation of hedged items, effectiveness measurement,
presentation and disclosure. The amended guidance has had no material impact on the Company’s existing foreign-exchange hedge
strategy and hedge transactions classified as cash flow hedge.
Accounting pronouncements
that are not yet effective and have not been adopted by the Company
In June 2016, the FASB issued new guidance
on measuring credit losses for financial instruments. The objective of the new guidance is to provide financial statement users
with more decision-useful information about the expected credit losses on financial instruments, primarily financial assets measured
at amortized cost and available-for-sale debt securities, and other commitments to extend credit held by a reporting entity at
each reporting date. The amended guidance replaces the incurred loss impairment methodology applied in current practice with an
approach that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information
to inform credit losses estimates. The new guidance is effective for public companies for fiscal years beginning after December
15, 2019, including interim periods within those years. The Company will adopt the new credit impairment model when effective and
is currently finalizing its review on the impact it will have on the measurement of financial assets in the scope of the new guidance.
The Company does not expect any material impact from the new credit impairment model applicable to available-for-sale debt securities,
as the Company only classifies in this category U.S. Treasury debt securities held as marketable securities. The Company is still
reviewing the impact the currently expected credit loss (“CECL”) model may have on financial assets measured at amortized
cost, including Trade accounts receivable.
In January 2017, the FASB simplified the
accounting for goodwill impairment by removing step 2 of the goodwill impairment test, which requires a hypothetical purchase price
allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value.
The amended guidance is effective for public companies for annual and interim periods in fiscal years beginning after December
15, 2019, with early application permitted for goodwill impairment tests with measurement dates after January 1, 2017. The Company
will adopt the new guidance when effective and does not expect any material impact on its consolidated financial statements.
In August 2018, the FASB clarifies the
accounting for costs of implementation activities performed in a cloud computing arrangement that is a service contract. The amended
guidance align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract
with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements
that include an internal-use software license). The amended guidance is effective for public companies for annual and interim periods
in fiscal years beginning after December 15, 2019. The Company will adopt the new guidance when effective and is currently finalizing
its review of the impact the amended guidance may have on its consolidated financial statements.
|
6.
|
Other Income and Expenses, Net
|
Other income and expenses, net consisted
of the following:
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Research and development funding
|
14
|
13
|
64
|
34
|
Phase-out and start-up costs
|
(15)
|
-
|
(22)
|
-
|
Exchange gain (loss), net
|
(1)
|
1
|
(1)
|
4
|
Patent costs
|
(1)
|
(2)
|
(1)
|
(7)
|
Gain on sale of businesses and non-current assets
|
-
|
-
|
6
|
7
|
Other, net
|
1
|
(1)
|
3
|
-
|
Total
|
(2)
|
11
|
49
|
38
|
The Company receives significant public
funding from governmental agencies in several jurisdictions. Public funding for research and development is recognized ratably
as the related costs are incurred once the agreement with the respective governmental agency has been signed and all applicable
conditions have been met.
Phase-out costs are costs incurred during
the closing stage of a Company’s manufacturing facility. They are treated in the same manner as start-up costs. Start-up
costs represent costs incurred in the start-up and testing of the Company’s new manufacturing facilities, before reaching
the earlier of a minimum level of production or six months after the fabrication line’s quality certification.
Exchange gains and losses, net represent
the portion of exchange rate changes on transactions denominated in currencies other than an entity’s functional currency
and the changes in fair value of trading derivative instruments which are not designated as hedge and which have a cash flow effect
related to operating transactions, as described in Note 27.
Patent costs include legal and attorney
fees and payment for claims, patent pre-litigation consultancy and legal fees. They are reported net of settlements, if any, which
primarily include reimbursements of prior patent litigation costs.
Gain on sale of businesses and non-current
assets for the first nine months of 2019 was related to the sale of one of our non-strategic assets.
|
7.
|
Impairment, Restructuring Charges and Other Related Closure Costs
|
The Company did not incur any significant
impairment, restructuring charges and other related closure costs in the third quarter and first nine months of 2019.
Impairment, restructuring charges and other
related closure costs incurred in the first nine months of 2018 are summarized as follows:
|
Nine months ended on September 29, 2018
|
|
Impairment
|
Restructuring charges
|
Other related closure costs
|
Total impairment, restructuring charges and other related closure costs
|
Set-top Box restructuring plan
|
-
|
(20)
|
-
|
(20)
|
Total
|
-
|
(20)
|
-
|
(20)
|
Impairment charges
No significant impairment charges were
incurred in the third quarter of 2019. In the first nine months of 2019, the Company incurred a $2 million impairment charge on
equipment dedicated exclusively to a development project that was cancelled and for which no alternative future use was identified.
During the third quarter of 2019 and 2018, the Company conducted its annual impairment test, which did not result in an impairment
loss.
Restructuring charges
and other related closure costs
Provisions for restructuring charges and
other related closure costs as at September 28, 2019 are summarized as follows:
|
Set-top Box restructuring plan
|
Other restructuring initiatives
|
Total
|
Provision as at December 31, 2018
|
34
|
1
|
35
|
Adjustment on unused provisions
|
(1)
|
-
|
(1)
|
Amounts paid
|
(16)
|
(1)
|
(17)
|
Currency translation effect
|
(1)
|
-
|
(1)
|
|
Provision as at September 28, 2019
|
16
|
-
|
16
|
|
|
|
|
|
|
•
|
Set-top Box restructuring plan
|
In 2016, the Company announced its decision
to cease the development of new platforms and standard products for set-top-box and home gateway products. This decision implied
a global workforce review of approximately 1,400 employees worldwide, which included about 430 employees in France through a voluntary
departure plan, about 670 employees in Asia and about 120 employees in the United States of America. The Company recorded in the
first nine months of 2018, $20 million of restructuring charges for this plan relating to employee termination benefits, primarily
for voluntary terminations in France.
Total impairment, restructuring charges and other
related closure costs
The Set-top Box restructuring plan was
expected to result in pre-tax charges of approximately $170 million. Since inception, restructuring charges, totaling $135 million,
were incurred as of September 28, 2019. The plan was substantially completed in 2018 in all locations. The Company still incurs
payments related to the voluntary plan in France.
|
8.
|
Interest income (expense), Net
|
Interest income (expense), net consisted
of the following:
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Income
|
13
|
12
|
43
|
32
|
Expense
|
(14)
|
(14)
|
(41)
|
(40)
|
Total
|
(1)
|
(2)
|
2
|
(8)
|
Interest income is related to the cash
and cash equivalents, short-term deposits and marketable securities held by the Company. Interest expense recorded in the first
nine months of 2019 included a $29 million charge on the senior unsecured convertible bonds issued on July 3, 2017, that was mainly
a non-cash interest expense resulting from the accretion of the discount on the liability component. Net interest includes also
charges related to the banking fees and the sale of trade and other receivables.
Income tax benefit (expense) is as follows:
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Income tax benefit (expense)
|
(28)
|
(24)
|
(93)
|
(68)
|
The annual estimated effective tax rate
method was applied, as management believes it provides a reliable estimate of the expected 2018 and 2019 income tax expense on
an interim basis. During the third quarter and first nine months of 2019, the Company registered an income tax expense of $28 million
and $93 million, respectively, reflecting the estimated annual effective tax rate in each of its jurisdictions, applied to the
third quarter of 2019 consolidated result before taxes. In addition, the Company’s income tax included the estimated impact
of provisions related to potential tax positions which have been considered uncertain.
At each reporting date, the Company assesses
all material open income tax positions in all tax jurisdictions to determine any uncertain tax position. The Company uses a two-step
process for the evaluation of uncertain tax positions. The first step consists in determining whether a benefit may be recognized;
the assessment is based on a sustainability threshold. If the sustainability is lower than 50%, a full provision should be accounted
for. In case of a sustainability threshold in step one higher than 50%, the Company must perform a second step in order to measure
the amount of recognizable tax benefit, net of any liability for tax uncertainties. The measurement methodology in step two is
based on a “cumulative probability” approach, resulting in the recognition of the largest amount that is greater than
50% likely of being realized upon settlement with the taxing authority. All unrecognized tax benefits affect the effective tax
rate, if recognized.
In May 2019, Switzerland voted a tax reform
which cancelled all favorable tax regimes and introduced a single tax rate for all companies, which triggered the revaluation of
all deferred tax assets and liabilities. Enactment of this law occurred in third quarter of 2019, which resulted in a tax benefit
of $20 million.
Basic net earnings per share (“EPS”)
is computed based on net income attributable to parent company stockholders using the weighted-average number of common shares
outstanding during the reported period; the number of outstanding shares does not include treasury shares. Diluted EPS is computed
using the weighted-average number of common shares and dilutive potential common shares outstanding during the period, such as
stock issuable pursuant to the exercise of stock options outstanding, unvested shares granted and the conversion of convertible
debt.
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
|
|
|
|
|
Basic EPS
|
|
|
|
|
|
|
|
|
|
Net income attributable to parent company
|
302
|
369
|
640
|
869
|
Weighted average shares outstanding
|
895,133,698
|
902,224,054
|
895,032,334
|
898,916,238
|
|
|
|
|
|
Basic EPS
|
0.34
|
0.41
|
0.34
|
0.97
|
|
|
|
|
|
Diluted EPS
|
|
|
|
|
|
|
|
|
|
Net income attributable to parent company
|
302
|
369
|
640
|
869
|
Weighted average shares outstanding
|
895,133,698
|
902,224,054
|
895,032,334
|
898,916,238
|
Dilutive effect of stock awards
|
4,964,050
|
5,334,417
|
6,539,875
|
8,070,747
|
Dilutive effect of convertible bonds
|
-
|
462,230
|
-
|
5,788,445
|
Number of shares used in calculating diluted EPS
|
900,097,748
|
908,020,701
|
901,572,209
|
912,775,430
|
|
|
|
|
|
Diluted EPS
|
0.34
|
0.41
|
0.71
|
0.95
|
For the nine months ended September 28,
2019, there was no dilutive effect of the senior convertible bonds issued on July 3, 2017 since the contingently conversion features
were out-of-the-money.
|
11.
|
Accumulated Other Comprehensive Income (“AOCI”)
|
The table below details the changes in
AOCI attributable to the company’s stockholders by component, net of tax, for the nine months ended September 28, 2019:
|
Gains (Losses) on Cash Flow Hedges
|
Gains (Losses) on Available-For-Sale Debt Securities
|
Defined Benefit Pension Plan Items
|
Foreign Currency Translation Adjustments (“CTA”)
|
Total
|
December 31, 2018
|
(39)
|
(2)
|
(179)
|
681
|
461
|
Cumulative tax impact
|
4
|
-
|
44
|
-
|
48
|
December 31, 2018, net of tax
|
(35)
|
(2)
|
(135)
|
681
|
509
|
OCI before reclassifications
|
(67)
|
3
|
(6)
|
(89)
|
(159)
|
Amounts reclassified from AOCI
|
63
|
-
|
9
|
-
|
72
|
OCI for the nine months ended September 28, 2019
|
(4)
|
3
|
3
|
(89)
|
(87)
|
Cumulative tax impact
|
-
|
-
|
-
|
-
|
-
|
OCI for the nine months ended September 28, 2019, net of tax
|
(4)
|
3
|
3
|
(89)
|
(87)
|
September 28, 2019
|
(43)
|
1
|
(176)
|
592
|
374
|
Cumulative tax impact
|
4
|
-
|
44
|
-
|
48
|
September 28, 2019 net of tax
|
(39)
|
1
|
(132)
|
592
|
422
|
Items reclassified out of Accumulated Other
Comprehensive Income for nine months period ended September 28, 2019 are listed in the table below:
Details about AOCI components
|
Amounts reclassified from AOCI
|
Affected line item in the statement where net income (loss) is presented
|
Gains (losses) on cash flow hedges
|
|
|
|
|
|
Foreign exchange derivative contracts
|
(41)
|
Cost of sales
|
|
|
|
Foreign exchange derivative contracts
|
(5)
|
Selling, general and administrative
|
|
|
|
Foreign exchange derivative contracts
|
(17)
|
Research and development
|
|
8
|
Income tax benefit (expense)
|
|
|
|
|
(55)
|
Net of tax
|
|
|
|
Defined benefit pension plan items
|
|
|
|
|
|
Amortization of actuarial gains (losses)
|
(9)
|
Other components of pension benefit costs(1)
|
|
2
|
Income tax benefit (expense)
|
|
|
|
|
(7)
|
Net of tax
|
|
|
|
Total reclassifications for the period attributable to the Company’s stockholders
|
(62)
|
Net of tax
|
(1) These items are included
in the computation of net periodic pension cost, as described in Note 23.
|
12.
|
Marketable Securities
|
Changes in the value of marketable securities,
as reported in current assets on the consolidated balance sheets as at September 28, 2019 and December 31, 2018 are detailed in
the table below:
|
December 31, 2018
|
Purchase
|
Sale / Redemption
|
Change in fair value included in OCI* for available-for-sale marketable securities
|
September 28, 2019
|
U.S. Treasury debt securities
|
330
|
-
|
(200)
|
3
|
133
|
Total
|
330
|
-
|
(200)
|
3
|
133
|
*Other Comprehensive Income
As at September 28, 2019, the Company held
$133 million of U.S. Treasury Bonds, all transferred to financial institutions with high credit quality. These transactions were
concluded in compliance with the Company’s policy to optimize the return on its short-term interest rate investments, always
placed with institutions with high credit rating. The Company, acting as the securities lender, does not hold any collateral on
the unsecured securities lending transactions. The Company retains effective control on the transferred securities. U.S. Treasury
Bonds totaling $200 million matured in the third quarter of 2019. The amount was reported as proceeds from matured marketable securities
in the consolidated statement of cash flows for the period ended September 28, 2019.
The debt securities had an average rating
of Aaa/AA+/AAA from Moody’s, S&P and Fitch, respectively. The outstanding $133 million U.S. Treasury bonds have an average
maturity of 1.8 years. The debt securities were reported as current assets on the line “Marketable Securities” on the
consolidated balance sheet as at September 28, 2019, since they represented investments of funds available for current operations.
The bonds were classified as available-for-sale and recorded at fair value as at September 28, 2019. This fair value measurement
corresponds to a Level 1 fair value hierarchy measurement. The aggregated amortized cost basis of these securities totaled $132
million as at September 28, 2019.
|
13.
|
Trade Accounts Receivable, Net
|
Trade accounts
receivable, net consisted of the following:
|
|
|
|
As at September 28, 2019
|
As at December 31, 2018
|
Trade accounts receivable
|
1,404
|
1,292
|
Allowance for doubtful accounts
|
(16)
|
(15)
|
Total
|
1,388
|
1,277
|
The Company enters from time to time into
factoring transactions to accelerate the realization in cash of some trade accounts receivable. During the first nine months ended
September 28, 2019, $75 million of trade accounts receivable were sold without recourse (nil as at December 31, 2018).
Inventories, net of reserve, consisted
of the following:
|
As at September 28, 2019
|
As at December 31, 2018
|
Raw materials
|
147
|
132
|
Work-in-process
|
1,186
|
1,005
|
Finished products
|
452
|
425
|
Total
|
1,785
|
1,562
|
Reserve for obsolescence is estimated for
excess uncommitted inventories based on the previous quarter’s sales, backlog of orders and production plans.
On February 6, 2019, the Company acquired
a majority stake in the Swedish silicon carbide (SiC) wafer manufacturer Norstel AB (“Norstel”). The Company acquired
55% of Norstel’s common stock, obtaining control over the entity. The fair value of the business as a whole was estimated
at $138 million, of which $77 million was paid by the Company for its majority stake, with an option to acquire the remaining 45%
at a later date, subject to certain conditions. The amount paid, net of $1 million of cash acquired, was funded with available
cash. An amount of $60 million is held in an escrow account and reported as current restricted cash in the consolidated balance
sheet as at September 28, 2019, should the Company exercise its purchase option.
This acquisition will extend the Company’s
silicon carbide ecosystem and strengthen the Company’s flexibility to serve fast growing automotive and industrial applications.
This transaction has been accounted for
as a business combination. The activities of this business are included in the Automotive and Discrete Group (ADG) reportable segment.
The purchase price allocation was finalized in the second quarter of 2019 and did not result in any material adjustments to the
preliminary allocation performed in the first quarter of 2019. The fair value of the identifiable assets and assumed liabilities
acquired from Norstel at acquisition date were as follows:
|
Fair value recognized at acquisition date
|
Property, plant and equipment
|
11
|
Technology in process
|
86
|
Net working capital
|
(2)
|
Goodwill(1)
|
43
|
Total net assets at fair value
|
138
|
Noncontrolling Interest
|
(61)
|
Purchase consideration
|
77
|
|
(1)
|
The primary item
that generated goodwill is the value of the future synergies between Norstel technology in silicon carbide and the Company which
do not qualify as an amortizable intangible asset.
|
Goodwill allocated to reportable segments
and changes in the carrying amount of goodwill were as follows:
|
Automotive and Discrete Group (ADG)
|
Analog, MEMS & Sensors Group (AMS)
|
Microcontrollers and Digital ICs Group (MDG)
|
Total
|
December 31, 2018
|
-
|
2
|
119
|
121
|
Business combination
|
43
|
-
|
-
|
43
|
Foreign currency translation
|
-
|
-
|
(3)
|
(3)
|
September 28, 2019
|
43
|
2
|
116
|
161
|
As described in Note 15, the acquisition
of Norstel resulted in the recognition of $43 million in goodwill which has been included in the ADG segment to align the goodwill
of the acquired Company with the segment for which the related activities will be reported.
|
17.
|
Other intangible assets
|
Other intangible assets consisted of the
following:
September 28, 2019
|
Gross Cost
|
Accumulated
Amortization
|
Net Cost
|
Technologies & licenses
|
690
|
(567)
|
123
|
Purchased & internally developed software
|
475
|
(419)
|
56
|
Technologies in progress
|
112
|
-
|
112
|
Other intangible assets
|
69
|
(69)
|
-
|
Total
|
1,346
|
(1,055)
|
291
|
December 31, 2018
|
Gross Cost
|
Accumulated
Amortization
|
Net Cost
|
Technologies & licenses
|
705
|
(592)
|
113
|
Purchased & internally developed software
|
459
|
(404)
|
55
|
Technologies in progress
|
44
|
-
|
44
|
Other intangible assets
|
69
|
(69)
|
-
|
Total
|
1,277
|
(1,065)
|
212
|
The line “Technologies in progress”
in the table above includes internally developed software under development and software not ready for use.
Amortization expense was $50 million and
$46 million for the first nine months of 2019 and 2018, respectively.
As described in Note 15, the acquisition
of Norstel resulted in the recognition of technology in process for $86 million in “Technologies in progress”.
The estimated amortization expense of the
existing intangible assets for each period is expected to be as follows:
Year
|
|
Remainder of 2019
|
20
|
2020
|
74
|
2021
|
57
|
2022
|
40
|
2023
|
23
|
Thereafter
|
77
|
Total
|
291
|
|
18.
|
Property, plant and equipment
|
Property, plant and equipment consisted
of the following:
|
|
|
|
September 28, 2019
|
Gross Cost
|
Accumulated Depreciation
|
Net Cost
|
|
|
|
|
Land
|
77
|
-
|
77
|
Buildings
|
889
|
(489)
|
400
|
Facilities & leasehold improvements
|
3,109
|
(2,699)
|
410
|
Machinery and equipment
|
14,937
|
(12,507)
|
2,430
|
Computer and R&D equipment
|
376
|
(330)
|
46
|
Operating lease right-of-use assets
|
248
|
(43)
|
205
|
Other tangible assets
|
111
|
(91)
|
20
|
Construction in progress
|
309
|
-
|
309
|
Total
|
20,056
|
(16,159)
|
3,897
|
|
|
|
|
December 31, 2018
|
Gross Cost
|
Accumulated Depreciation
|
Net Cost
|
|
|
|
|
Land
|
79
|
-
|
79
|
Buildings
|
902
|
(487)
|
415
|
Facilities & leasehold improvements
|
3,170
|
(2,748)
|
422
|
Machinery and equipment
|
14,882
|
(12,582)
|
2,300
|
Computer and R&D equipment
|
381
|
(334)
|
47
|
Other tangible assets
|
123
|
(93)
|
30
|
Construction in progress
|
202
|
-
|
202
|
Total
|
19,739
|
(16,244)
|
3,495
|
The line “Construction in progress”
in the table above includes property, plant and equipment under construction and equipment under qualification before operating.
Facilities & leasehold improvements,
machinery and equipment and other tangible assets include assets acquired under capital lease. The net cost of assets under capital
lease was nil at September 28, 2019 and less than $1 million at December 31, 2018.
On January 1, 2019, the Company adopted
the new guidance on lease accounting and operating lease right-of-use assets are now included in plant, property and equipment.
The impact of the adoption of this new guidance is further described in Note 19.
The depreciation charge was $584 million
and $533 million for the first nine months of 2019 and 2018, respectively.
As described in Note 15, the acquisition
of Norstel resulted in the recognition of property, plant and equipment for $11 million.
A lease contract is a contract, or part
of a contract, that conveys the right to control the use of identified property, plant, or equipment (an identified asset) for
a period of time in exchange for consideration. The Company determines if an arrangement is a lease at inception. Operating leases
are included in operating lease right-of-use assets within plant, property and equipment. Current operating lease liabilities are
included in other payables and accrued liabilities, while noncurrent operating lease liabilities are included in other long-term
liabilities in the Company’s consolidated balance sheet. Finance leases are included in property and equipment and long-term
debt.
Right-of-use assets represent the Company’s
right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease
payments arising from the lease. Right-of-use assets and liabilities are recognized at the lease commencement date based on the
estimated present value of lease payments over the lease term.
The right-of-use asset is a nonmonetary
asset while the lease liability is a monetary liability. When accounting for a lease that is denominated in a foreign currency,
the lease liability is remeasured using the current exchange rate, while the right-of-use asset is remeasured using the exchange
rate as of the commencement date.
The Company leases land, buildings, cars
and certain equipment (including IT equipment) which have remaining lease terms between less than one year and 38 years. Certain
lease contracts contain options to extend the leases by up to 30 years, which the Company has included in the lease term when it
is reasonably certain for the Company to exercise that option. In addition, the Company made an accounting policy election for
all the asset classes to not account for the short-term leases. A short-term lease is defined as a lease that, at the commencement
date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that the lessee is
reasonably certain to exercise. The short-term lease election can only be made at the commencement date.
Variable lease payments that depend on
an index or a rate are included in the lease payments and are measured using the prevailing index or rate at the measurement date
(January 1, 2019 for initial measurement of the leases existing at that date and commencement date for subsequent lease contracts).
Changes to index and rate-based variable lease payments are recognized in profit or loss in the period of the change.
Lease contracts with a sum of lease payments
not exceeding $5,000 have been excluded from the capitalization in the balance sheet.
Significant assumptions and judgements
may be made in applying the requirements of lease accounting, such as the exercise of extension options and determination of discount
rates.
Practical expedients
The Company applied the following practical
expedients at standard adoption:
1. Practical expedient to not separate
lease and non-lease components and instead to account for each separate lease component and the non-lease components associated
with that lease component as a single lease component. This practical expedient was applied to the real estate (land and buildings),
equipment, IT and cars.
2. The package of transition practical
expedients (elected as a package and applied consistently to all leases) not to reassess leases that commenced before the effective
date consisting in:
a) No need to reassess whether any expired
or existing contracts are or contain leases.
b) No need to reassess the lease classification
for any expired or existing leases.
c) No need to reassess initial direct costs
for any existing leases.
3. The transition option allowing to not
apply the new leases standard in the comparative periods presented in the financial statements in the year of adoption.
Discount rates
The rate implicit in the lease should be
used whenever that rate is readily determinable. In most cases, this rate is not readily determinable and the Company used its
incremental borrowing rate, which was derived from information available at the lease commencement date, in determining the present
value of lease payments. The Company gives consideration to its recent debt issuances as well as publicly available data for instruments
with similar characteristics when calculating its incremental borrowing rates. Discount rates at implementation were established
as of January 1, 2019. Going forward, due to immateriality of any intra-quarter discount rate changes, the Company will determine
the discount rate based on the mid-quarter date.
As of September 28, 2019 finance lease
right-of-use asset was less than $1 million. The below information is presented for the operating leases only.
Operating leases consisted of the following:
|
As at September 28, 2019
|
Assets
|
|
Operating lease assets
|
205
|
Total operating lease assets
|
205
|
|
|
Liabilities
|
|
Current
|
58
|
Noncurrent
|
146
|
Total operating lease liabilities
|
204
|
|
|
Undiscounted cash flows of operating lease
liabilities are as follows:
|
As at September 28, 2019
|
2019
|
17
|
2020
|
54
|
2021
|
39
|
2022
|
28
|
2023
|
21
|
Thereafter
|
95
|
Total future undiscounted cash outflows
|
254
|
Effect of discounting
|
(50)
|
Total operating lease liabilities
|
204
|
Operating lease term and discount rate
are as follows:
|
As at September 28, 2019
|
Weighted average remaining lease term (in years)
|
9.28
|
Weighted average discount rate
|
2.76%
|
Operating lease cost and cash paid for
the first nine months of 2019 are as follows:
|
As at September 28, 2019
|
Operating lease cost
|
49
|
Operating lease cash paid
|
48
|
|
20.
|
Long-Term Investments
|
Long-Term Investments consisted of the following:
|
September 28, 2019
|
December 31, 2018
|
Equity-method investments
|
51
|
49
|
Other long-term investments
|
11
|
12
|
Total
|
62
|
61
|
Equity-method investments
Equity-method investments as at September 28, 2019 and December 31, 2018 were as follows:
|
|
September 28, 2019
|
December 31, 2018
|
Carrying value
|
Ownership percentage
|
Carrying value
|
Ownership percentage
|
ST-Ericsson SA, in liquidation
|
51
|
50.0%
|
49
|
50.0%
|
Total
|
51
|
|
49
|
|
ST-Ericsson SA, in liquidation
On February 3, 2009, the Company announced
the closing of a transaction to combine the businesses of Ericsson Mobile Platforms and ST-NXP Wireless into a new venture, named
ST-Ericsson. As part of the transaction, the Company received an interest in ST-Ericsson Holding AG in which the Company owned
50% plus a controlling share. In 2010, ST-Ericsson Holding AG was merged in ST-Ericsson SA.
The Company evaluated that ST-Ericsson
SA was a variable interest entity (VIE). The Company determined that it controlled ST-Ericsson SA and therefore consolidated ST-Ericsson
SA.
On September 9, 2013, the Company sold
1 ST-Ericsson SA share to Ericsson for its nominal value changing the ownership structure of ST-Ericsson SA to bring both partners
to an equal ownership proportion. As a result and in combination with the new shareholder agreement, the Company lost the control
of ST-Ericsson SA and as such ST-Ericsson SA was deconsolidated from the Company’s financial statements. The deconsolidation
of ST-Ericsson SA did not result in a gain or loss for the Company. The fair value of the Company’s retained noncontrolling
interest was evaluated at $55 million. In addition, the Company and its partner signed funding commitment letters, capped at $149
million for each partner, to the residual joint wind-down operations to ensure solvency. These were not drawn as of September 28,
2019.
Before the deconsolidation of ST-Ericsson
SA, certain assets and companies of the ST-Ericsson SA group of companies were transferred to both partners for their net book
value which was representative of their fair value. The transactions did not result in cash exchange between the partners. ST-Ericsson
SA entered into liquidation on April 15, 2014.
Other long-term investments
Other long-term investments are equity
securities with no readily determinable fair value for which the Company has elected to apply the cost alternative measurement.
It includes principally the Company’s investment in DNP Photomask Europe S.p.A (“DNP”). The Company has identified
the joint venture as a VIE, but has determined that it is not the primary beneficiary. The significant activities of DNP revolve
around the creation of masks and development of high level mask technology. The Company does not have the power to direct such
activities. The Company’s current maximum exposure to loss as a result of its involvement with the joint venture is limited
to its investment. The Company has not provided additional financial support in the first nine months of 2019 and currently has
no requirement or intent to provide further financial support to the joint venture.
|
21.
|
Other Non-current Assets
|
Other non-current assets consisted of the
following:
|
|
|
|
As at September 28, 2019
|
As at December 31, 2018
|
Equity securities
|
22
|
19
|
Long-term State receivables
|
326
|
391
|
Deposits and other non-current assets
|
53
|
42
|
Total
|
401
|
452
|
Long-term State receivables include receivables
related to funding and receivables related to tax refunds. Funding are mainly public grants to be received from governmental agencies
in Italy and France as part of long-term research and development, industrialization and capital investment projects.
During the first nine months of 2019, the
Company entered into a factoring transaction to accelerate the realization in cash of some non-current assets. As at September
28, 2019, $131 million of the non-current assets were sold without recourse, with a financial cost of less than $1 million.
Long-term debt consisted of the following:
|
September 28, 2019
|
December 31, 2018
|
|
|
|
|
Funding program loans from European Investment Bank:
|
|
|
|
3.38% due 2020, floating interest rate at Libor + 1.099%
|
25
|
25
|
|
3.07% due 2020, floating interest rate at Libor + 0.956%
|
55
|
55
|
|
0.45% due 2020, floating interest rate at Euribor + 0.817%
|
28
|
29
|
|
3.14% due 2021, floating interest rate at Libor + 0.525%
|
90
|
90
|
|
3.13% due 2021, floating interest rate at Libor + 0.572%
|
86
|
86
|
|
0.36% due 2028, floating interest rate at Euribor + 0.589%
|
279
|
292
|
|
0.21% due 2029, floating interest rate at Euribor + 0.564%
|
268
|
-
|
|
Dual tranche senior unsecured convertible bonds
|
|
|
|
Zero-coupon due 2022 (Tranche A)
|
695
|
681
|
|
0.25% due 2024 (Tranche B)
|
649
|
635
|
|
Other funding program loans:
|
|
|
|
0.31% (weighted average), due 2019-2023, fixed interest rate
|
14
|
16
|
|
Other long-term loans:
|
|
|
|
0.87% (weighted average), due 2020, fixed interest rate
|
1
|
1
|
|
Total long-term debt
|
2,190
|
1,910
|
|
Less current portion
|
(171)
|
(146)
|
|
Total long-term debt, less current portion
|
2,019
|
1,764
|
|
|
|
|
On July 3, 2017,
the Company issued a $1.5 billion principal amount of dual tranche senior unsecured convertible bonds (Tranche A and Tranche B
for $750 million each tranche), due 2022 and 2024, respectively. Tranche A bonds were issued at 101.265% as zero-coupon bonds while
Tranche B bonds were issued at par and bear a 0.25% per annum nominal interest, payable semi-annually. The conversion price at
issuance was $20.54 dollar, equivalent to a 37.5% premium on both tranches, which corresponds to 9,737 equivalent shares per each
$200,000 bond par value. The bonds are convertible by the bondholders or are callable by the issuer upon certain conditions, on
a net-share settlement basis, except if the issuer elects a full-cash or full-share conversion as an alternative settlement. The
net proceeds from the bond offering were $1,502 million, after deducting issuance costs payable by the Company. Proceeds were allocated
between debt and equity by measuring first the liability component and then determining the equity component as a residual amount.
The liability component was measured at fair value based on a discount rate adjustment technique (income approach), which corresponded
to a Level 3 fair value hierarchy measurement. The fair value of the liability component at initial recognition totaled $1,266
million before allocation of issuance costs, and was estimated by calculating the present value of cash flows using a discount
rate of 2.70% and 3.28% (including 0.25% per annum nominal interest), respectively, on each tranche, which were determined to be
consistent with the market rates at the time for similar instruments with no conversion rights. An amount of $242 million, net
of allocated issuance costs of $1 million, was recorded in shareholders’ equity as the value of the conversion features of
the instruments. Unamortized debt discount and issuance costs on the newly issued convertible debt totaled $156 million as at September
28, 2019. As at September 28, 2019, the Company stock price did not exceed the conversion price of the new convertible bonds.
In August 2017, the Company signed a new
long-term credit facility with the European Investment Bank for a total of €500 million in relation to R&D and capital
expenditure investments in the European Union for the years 2017 and 2018. As of September 28, 2019, the entire amount was fully
drawn in Euros corresponding to $547 million outstanding as of September 28, 2019.
|
23.
|
Post Employment and Other Long-term Employee Benefits
|
The Company and its subsidiaries have a
number of defined benefit pension plans, mainly unfunded, and other long-term employees’ benefits covering employees in various
countries. The defined benefit plans provide pension benefits based on years of service and employee compensation levels. The other
long-term employees’ plans provide benefits due during the employees’ period of service after certain seniority levels.
The Company uses a December 31 measurement date for its plans. Eligibility is generally determined in accordance with local statutory
requirements. For the Italian termination indemnity plan (“TFR”) generated before July 1, 2007, the Company continues
to measure the vested benefits to which Italian employees are entitled as if they left the company immediately as of September
28, 2019, in compliance with U.S. GAAP guidance on determining vested benefit obligations for defined benefit pension plans.
The components of the net periodic benefit
cost included the following:
|
Pension Benefits
|
Pension Benefits
|
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Service cost
|
(7)
|
(7)
|
(21)
|
(21)
|
Interest cost
|
(6)
|
(7)
|
(19)
|
(19)
|
Expected return on plan assets
|
5
|
6
|
16
|
17
|
Amortization of actuarial net gain (loss)
|
(2)
|
(2)
|
(7)
|
(6)
|
Effect of settlement
|
(2)
|
-
|
(2)
|
-
|
Net periodic benefit cost(1)
|
(12)
|
(10)
|
(33)
|
(29)
|
|
(1)
|
Defined benefit plan expense
components other than service cost, representing $12 million and $9 million in the first nine months of 2019 and 2018, respectively,
were recognized outside of Operating income in “Other components of pension benefit costs” in our Consolidated Statements
of Income. Service cost was recognized within Operating income.
|
|
Other long-term benefits
|
Other long-term benefits
|
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Service cost
|
(1)
|
(1)
|
(3)
|
(3)
|
Interest cost
|
-
|
-
|
(1)
|
(1)
|
Net periodic benefit cost
|
(1)
|
(1)
|
(4)
|
(4)
|
Employer contributions paid and expected
to be paid in 2019 are consistent with the amounts disclosed in the consolidated financial statements for the year ended December
31, 2018.
The Annual General Meeting of Shareholders
held on May 23, 2019 authorized the distribution of a cash dividend of $0.24 per outstanding share of the Company’s common
stock, to be distributed in quarterly installments of $0.06 in each of the second, third and fourth quarters of 2019 and first
quarter of 2020. The amount of $48 million related to the first installment was paid during the second quarter of 2019, while the
remaining portion of $6 million was paid during the third quarter of 2019. The second instalment was paid partially in the third
quarter for an amount of $48 million. The remaining portion of the second instalment and the $0.18 per share cash dividend corresponding
to the last two instalments totaled $112 million and is presented in the line “Dividends payable to stockholders” in
the consolidated balance sheet as of September 28, 2019.
The Annual General Meeting of Shareholders
held on May 31, 2018 authorized the distribution of a cash dividend of $0.24 per outstanding share of the Company’s common
stock, to be distributed in quarterly installments of $0.06 in each of the second, third and fourth quarters of 2018 and first
quarter of 2019. The amount of $54 million corresponding to the first installment, $54 million corresponding to the second installment
and $48 million corresponding to the third installment were paid as of December 31, 2018. The remaining portion of the third instalment
amounting to $6 million and the fourth instalment of $54 million were paid in the first half of 2019.
The Annual General Meeting of Shareholders
held on June 20, 2017 authorized the distribution of a cash dividend of $0.24 per outstanding share of the Company’s common
stock, to be distributed in quarterly installments of $0.06 in each of the second, third and fourth quarters of 2017 and first
quarter of 2018. The amount of $53 million corresponding to the first installment, $53 million corresponding to the second installment,
$47 million corresponding to the third installment were paid as of December 31, 2017. The remaining portion of the third installment
amounting to $7 million and the last installment of $53 million were paid in the first half of 2018.
The treasury shares have been designated
for allocation under the Company’s share based remuneration programs of unvested shares. Through September 28, 2019, 53,157,712
of these treasury shares were transferred to employees under the Company’s share based remuneration programs, of which 6,948,170
were transferred in the first nine months of 2019.
On November 5, 2018, the Company announced
a three years share buy-back program of up to $750 million. During the first nine months of 2019, the Company repurchased 11.2
million shares of its common stock for a total of $187 million, under the share buy-back program, reflected at cost, as a reduction
of the parent company stockholders’ equity.
As of September 28, 2019, the Company held
17,078,471 treasury shares.
|
26.
|
Contingencies, Claims and Legal proceedings
|
The Company is subject to possible loss
contingencies arising in the ordinary course of business. These include but are not limited to: warranty cost on the products of
the Company, breach of contract claims, claims for unauthorized use of third-party intellectual property, tax claims beyond assessed
uncertain tax positions as well as claims for environmental damages. In determining loss contingencies, the Company considers the
likelihood of impairing an asset or the incurrence of a liability at the date of the financial statements as well as the ability
to reasonably estimate the amount of such loss. The Company records a provision for a loss contingency when information available
before the financial statements are issued or are available to be issued indicates that it is probable that an asset has been impaired
or a liability has been incurred at the date of the financial statements and when the amount of loss can be reasonably estimated.
The Company regularly reevaluates claims to determine whether provisions need to be readjusted based on the most current information
available to the Company. Changes in these evaluations could result in an adverse material impact on the Company’s results
of operations, cash flows or its financial position for the period in which they occur.
The Company has received and may in the
future receive communications alleging possible infringements of third party patents or other third party intellectual property
rights. Furthermore, the Company from time to time enters into discussions regarding a broad patent cross license arrangement with
other industry participants. There is no assurance that such discussions may be brought to a successful conclusion and result in
the intended agreement. The Company may become involved in costly litigation brought against the Company regarding patents, mask
works, copyrights, trademarks or trade secrets. In the event that the outcome of any litigation would be unfavorable to the Company,
the Company may be required to take a license to third party patents and/or other intellectual property rights at economically
unfavorable terms and conditions, and possibly pay damages for prior use and/or face an injunction, all of which individually or
in the aggregate could have a material adverse effect on the Company’s results of operations, cash flows, financial position
and/or ability to compete.
The Company is otherwise also involved
in various lawsuits, claims, investigations and proceedings incidental to its business and operations.
The Company regularly evaluates claims
and legal proceedings together with their related probable losses to determine whether they need to be adjusted based on the current
information available to the Company. There can be no assurance that its recorded provisions will be sufficient to cover the extent
of its potential liabilities. Legal costs associated with claims are expensed as incurred. In the event of litigation which is
adversely determined with respect to the Company’s interests, or in the event the Company needs to change its evaluation
of a potential third-party claim, based on new evidence or communications, a material adverse effect could impact its operations
or financial condition at the time it were to materialize.
As of September 28, 2019, provisions for
estimated probable losses with respect to claims and legal proceedings were not considered material.
|
27.
|
Derivative Instruments and Hedging Activities
|
The Company is exposed to changes in financial
market conditions in the normal course of business due to its operations in different foreign currencies and its ongoing investing
and financing activities. The Company’s activities expose it to a variety of financial risks, such as market risk, credit
risk and liquidity risk. The Company uses derivative financial instruments to hedge certain risk exposures. The primary risk managed
by using derivative instruments is foreign currency exchange risk.
Foreign currency exchange
risk
Currency forward contracts and currency
options are entered into to reduce exposure to changes in exchange rates on the denomination of certain assets and liabilities
in foreign currencies at the Company’s subsidiaries and to manage the foreign exchange risk associated with certain forecasted
transactions.
Derivative Instruments Not Designated
as a Hedge
The Company conducts its business on a
global basis in various major international currencies. As a result, the Company is exposed to adverse movements in foreign currency
exchange rates, primarily with respect to the Euro. Foreign exchange risk mainly arises from future commercial transactions and
recognized assets and liabilities in the Company’s subsidiaries. Management has set up a policy to require the Company’s
subsidiaries to hedge their entire foreign exchange risk exposure with the Company through financial instruments transacted or
overseen by Corporate Treasury. To manage their foreign exchange risk arising from foreign-currency-denominated assets and liabilities,
the Company and its subsidiaries use forward contracts and purchased currency options. Foreign exchange risk arises from exchange
rate fluctuations on assets and liabilities denominated in a currency that is not the entity’s functional currency. These
instruments do not qualify as hedging instruments for accounting purposes and are marked-to-market at each period-end with the
associated changes in fair value recognized in “Other income and expenses, net” in the consolidated statements of income.
Cash Flow Hedge
To further reduce its exposure to U.S.
dollar exchange rate fluctuations, the Company hedges through the use of currency forward contracts and currency options, including
collars, certain Euro-denominated forecasted intercompany transactions that cover at reporting date a large part of its research
and development, selling, general and administrative expenses as well as a portion of its front-end manufacturing costs of semi-finished
goods within cost of sales. The Company also hedges through the use of currency forward contracts certain forecasted manufacturing
transactions denominated in Singapore dollars.
These derivative instruments are designated
as and qualify for cash flow hedge. They are reflected at fair value in the consolidated balance sheets. The criteria for designating
a derivative as a hedge include the instrument’s effectiveness in risk reduction and, in most cases, a one-to-one matching
of the derivative instrument to its underlying transaction, which enables the Company to conclude, based on the fact that the critical
terms of the hedging instruments match the terms of the hedged transactions, that changes in cash flows attributable to the risk
being hedged are expected to be completely offset by the hedging derivatives. Currency forward contracts and currency options,
including collars, used as hedges are highly effective at reducing the Euro/U.S. dollar and the Singapore dollar/U.S. dollar currency
fluctuation risk and are designated as a hedge at the inception of the contract and on an ongoing basis over the duration of the
hedge relationship. Effectiveness on transactions hedged through purchased currency options and collars is measured on the full
fair value of the instrument, including the time value of the options. Ineffectiveness appears if the hedge relationship is not
perfectly effective or if the cumulative gain or loss on the derivative hedging instrument exceeds the cumulative change on the
expected cash flows on the hedged transactions. The whole change in fair value recorded on the hedging instrument is reported as
a component of “Accumulated other comprehensive income (loss)” in the consolidated statements of equity and is reclassified
into earnings in the same period in which the hedged transaction affects earnings, and within the same consolidated statement of
income line item as the impact of the hedged transaction.
The principles regulating the hedging strategy
for derivatives designated as cash flow hedge are established as follows: (i) for R&D and Corporate costs, up to 80% of the
total forecasted transactions; (ii) for manufacturing costs, up to 70% of the total forecasted transactions. The maximum length
of time over which the Company could hedge its exposure to the variability of cash flows for forecasted transactions is 24 months.
As at September 28, 2019, the Company had
the following outstanding derivative instruments that were entered into to hedge Euro-denominated and Singapore dollar-denominated
forecasted transactions:
In millions of Euros
|
Notional amount for hedge on forecasted R&D and other operating expenses
|
Notional amount for hedge on forecasted manufacturing costs
|
|
|
|
Forward contracts
|
236
|
379
|
Currency collars
|
263
|
369
|
|
|
|
In millions of Singapore dollars
|
Notional
amount for hedge on forecasted R&D and other operating expenses
|
Notional
amount for hedge on forecasted manufacturing costs
|
|
|
|
Forward contracts
|
-
|
165
|
Cash flow and fair
value interest rate risk
The Company’s interest rate risk
arises from long-term borrowings. Borrowings issued at variable rates expose the Company to cash flow interest rate risk. Borrowings
issued at fixed rates expose the Company to fair value interest rate risk. The Company analyzes its interest rate exposure on a
dynamic basis. Various scenarios are simulated taking into consideration refinancing, renewal of existing positions, alternative
financing and hedging. The Company invests primarily on a short-term basis and as such the Company’s liquidity is invested
in floating interest rate instruments. As a consequence, the Company is exposed to interest rate risk due to potential mismatch
between the return on its short term floating interest rate investments and the portion of its long term debt issued at fixed rate.
Other market risk
As part of its ongoing investing activities,
the Company might be exposed to equity security price risk. Therefore the Company’s procedures allow it to enter into certain
hedging transactions.
For a complete description of exposure
to market risks, including credit risk, these interim financial statements should be read in conjunction with the Consolidated
Financial Statements in the Company’s Annual Report on Form 20-F for the year ended December 31, 2018.
Information on fair value of derivative
instruments and their location in the consolidated balance sheets as at September 28, 2019 and December 31, 2018 is presented in
the table below:
|
As at September 28, 2019
|
As at December 31, 2018
|
Asset Derivatives
|
Balance sheet location
|
Fair value
|
Balance sheet location
|
Fair value
|
Derivatives designated as a hedge:
|
|
|
|
|
Foreign exchange forward contracts
|
Other current assets
|
-
|
Other current assets
|
2
|
Total derivatives designated as a hedge:
|
|
-
|
|
2
|
Derivatives not designated as a hedge:
|
|
|
|
|
Foreign exchange forward contracts
|
Other current assets
|
1
|
Other current assets
|
3
|
Total derivatives not designated as a hedge:
|
|
1
|
|
3
|
Total Derivatives
|
|
1
|
|
5
|
|
As at September 28, 2019
|
As at December 31, 2018
|
Liability Derivatives
|
Balance sheet location
|
Fair value
|
Balance sheet location
|
Fair value
|
Derivatives designated as a hedge:
|
|
|
|
|
Foreign exchange forward contracts
|
Other payables and accrued liabilities
|
(23)
|
Other payables and accrued liabilities
|
(22)
|
Foreign exchange forward contracts
|
Other long-term liabilities
|
(1)
|
Other long-term liabilities
|
-
|
Currency collars
|
Other payables and accrued liabilities
|
(12)
|
Other payables and accrued liabilities
|
(11)
|
Total derivatives designated as a hedge:
|
|
(36)
|
|
(33)
|
Derivatives not designated as a hedge:
|
|
|
|
|
Foreign exchange forward contracts
|
Other payables and accrued liabilities
|
(2)
|
Other payables and accrued liabilities
|
(1)
|
Total derivatives not designated as a hedge:
|
|
(2)
|
|
(1)
|
Total Derivatives
|
|
(38)
|
|
(34)
|
The effect on the consolidated statements
of income for the three and nine months ended September 28, 2019 and September 29, 2018, respectively, and on the “Accumulated
Other comprehensive income (loss)” (“AOCI”) as reported in the statements of equity as at September 28, 2019
and December 31, 2018 of derivative instruments designated as cash flow hedge is presented in the table below:
|
Gain (loss) deferred in OCI on derivative
|
Location of gain (loss) reclassified from OCI into earnings
|
Gain (loss) reclassified from OCI into earnings
|
|
|
|
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
December 31, 2018
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Foreign exchange forward contracts
|
(18)
|
(18)
|
Cost of sales
|
(7)
|
(11)
|
(28)
|
10
|
Foreign exchange forward contracts
|
(2)
|
(1)
|
Selling, general and administrative
|
(1)
|
(1)
|
(3)
|
1
|
Foreign exchange forward contracts
|
(7)
|
(6)
|
Research and development
|
(3)
|
(4)
|
(12)
|
2
|
Currency collars
|
(10)
|
(9)
|
Cost of sales
|
(5)
|
(3)
|
(13)
|
9
|
Currency collars
|
(1)
|
(1)
|
Selling, general and administrative
|
-
|
-
|
(2)
|
-
|
Currency collars
|
(5)
|
(4)
|
Research and development
|
(1)
|
(1)
|
(5)
|
4
|
Total
|
(43)
|
(39)
|
|
(17)
|
(20)
|
(63)
|
26
|
A total $42 million loss deferred as at
September 28, 2019 in AOCI is expected to be reclassified to earnings within the next twelve months.
No amount was excluded from effectiveness
measurement on foreign exchange forward contracts and currency collars. No ineffective portion of the cash flow hedge relationships
was recorded on the hedge transactions that were settled in the first nine months of 2019 and 2018. No ineffectiveness is to be
reported on hedge transactions outstanding as at September 28, 2019.
The effect on the consolidated statements
of income for the three and nine months ended September 28, 2019 and September 29, 2018 of derivative instruments not designated
as a hedge is presented in the table below:
|
Location of gain (loss) recognized in earnings
|
Gain recognized in earnings
|
|
|
Three months ended
|
Nine months ended
|
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Foreign exchange forward contracts
|
Other income and expenses, net
|
(1)
|
(3)
|
3
|
9
|
Total
|
|
(1)
|
(3)
|
3
|
9
|
The Company did not enter into any derivative
instrument containing credit-risk-related contingent features.
The Company entered into currency collars
as combinations of two options, which are reported, for accounting purposes, on a net basis. The fair value of these collars represented
liabilities for a net amount of $12 million (composed of $1 million asset with a $13 million liability) as at September 28, 2019.
In addition, the Company entered into other derivative instruments, primarily forward contracts, which are governed by standard
International Swaps and Derivatives Association (“ISDA”) agreements and are compliant with Protocols of the European
Market Infrastructure Regulation (“EMIR”), which are not offset in the statement of financial position, and representing
total assets of $1 million and total liabilities of $26 million as at September 28, 2019.
|
28.
|
Fair Value Measurements
|
The table below details financial assets
(liabilities) measured at fair value on a recurring basis as at September 28, 2019:
|
|
Fair Value Measurements using
|
|
September 28, 2019
|
Quoted Prices in Active Markets for Identical Assets (Level 1)
|
Significant Other Observable Inputs
(Level 2)
|
Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
|
Marketable securities – U.S. Treasury debt securities
|
133
|
133
|
-
|
-
|
Equity securities measured at fair value through earnings
|
22
|
22
|
-
|
-
|
Derivative assets not designated as cash flow hedge
|
1
|
-
|
1
|
-
|
Derivative liabilities designated as cash flow hedge
|
(36)
|
-
|
(36)
|
-
|
Derivative liabilities not designated as cash flow hedge
|
(2)
|
-
|
(2)
|
-
|
Total
|
118
|
155
|
(37)
|
-
|
The table below details financial assets
(liabilities) measured at fair value on a recurring basis as at December 31, 2018:
|
|
Fair Value Measurements using
|
|
December 31, 2018
|
Quoted Prices in Active Markets for Identical Assets (Level 1)
|
Significant Other Observable Inputs
(Level 2)
|
Significant Unobservable Inputs
(Level 3)
|
|
|
|
|
|
Marketable securities – U.S. Treasury debt securities
|
330
|
330
|
-
|
-
|
Equity securities measured at fair value through earnings
|
19
|
19
|
-
|
-
|
Derivative assets designated as cash flow hedge
|
2
|
-
|
2
|
-
|
Derivative liabilities designated as cash flow hedge
|
(33)
|
-
|
(33)
|
-
|
Derivative assets not designated as cash flow hedge
|
3
|
-
|
3
|
-
|
Derivative liabilities not designated as cash flow hedge
|
(1)
|
-
|
(1)
|
-
|
Total
|
320
|
349
|
(29)
|
-
|
There was no material asset (liability)
measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as at September 28, 2019.
For assets (liabilities) measured at fair
value on a recurring basis using significant unobservable inputs (Level 3), the reconciliation between January 1, 2018 and September
29, 2018 is presented as follows:
|
Fair Value Measurements using Significant
Unobservable Inputs (Level 3)
|
January 1, 2018
|
(12)
|
Revaluation of contingent consideration on business combination
|
-
|
September 29, 2018
|
(12)
|
|
|
Amount of total losses for the period included in earnings attributable to assets still held at the reporting date
|
-
|
No asset (liability) was measured at fair
value on a non-recurring basis using significant unobservable inputs (Level 3) as at
September 28, 2019 and September 29, 2018
respectively. On February 6, 2019, the Company acquired a majority stake in Swedish silicon carbide (SiC) wafer manufacturer Norstel
AB (“Norstel”), as detailed in Note 15. The purchase price allocation on the assets acquired and assumed liabilities,
measured at fair value, was determined by the Company with the assistance of a third party. This corresponds to a Level 3 fair
value hierarchy measurement. The main asset that was identified separately corresponded to IP R&D (technology-based intangible
asset) and amounted to $86 million. The fair value of the intangible asset was determined using the average of the replacement
cost method and a discounted cash flow approach (“with and without method”) consisting in discounting at a 12.5% discount
rate future cost savings, less capital expenditures necessary to produce silicon carbide wafers in-house over a 15-year period.
The following table includes additional
fair value information on other financial assets and liabilities as at September 28, 2019 and December 31, 2018:
|
|
As at September 28, 2019
|
As at December 31, 2018
|
|
Level
|
Carrying Amount
|
Estimated Fair Value
|
Carrying Amount
|
Estimated Fair Value
|
|
|
|
|
|
|
Cash equivalents(1)
|
1
|
1,461
|
1,461
|
2,138
|
2,138
|
Long-term debt
|
|
|
|
|
|
- Bank loans (including current portion)
|
2
|
846
|
846
|
594
|
594
|
- Senior unsecured convertible bonds(2)
|
1
|
1,344
|
1,772
|
1,316
|
1,501
|
|
|
|
|
|
|
(1) Cash equivalents primarily correspond to deposits
at call with banks.
(2) The carrying amount of the
senior unsecured convertible bonds issued on July 3, 2017 as reported above corresponds to the liability component only, since,
at initial recognition, an amount of $242 million was recorded directly in shareholders’ equity as the value of the equity
instrument embedded in the issued convertible bonds. The initial recognition of the convertible bonds is further described in Note
22, Long-term Debt.
The Company did not report securities that
were in an unrealized loss position as at September 28, 2019. The table below details securities that were in an unrealized loss
position as at December 31, 2018. The securities are segregated by investment type and length of time that the individual securities
have been in a continuous unrealized position as at December 31, 2018.
|
December 31, 2018
|
|
Less than 12 months
|
More than 12 months
|
Total
|
Description
|
Fair Values
|
Unrealized Losses
|
Fair Values
|
Unrealized Losses
|
Fair Values
|
Unrealized Losses
|
U.S. Treasury Bonds
|
-
|
-
|
330
|
(2)
|
330
|
(2)
|
Total
|
-
|
-
|
330
|
(2)
|
330
|
(2)
|
The methodologies used to estimate fair
value are as follows:
Debt securities classified as available-for-sale
The fair value of these debt securities
is estimated based upon quoted market prices for identical instruments.
Foreign exchange forward contracts, currency
options and collars
The fair value of these instruments is
estimated based upon quoted market prices for similar instruments.
Equity securities measured at fair value
through earnings
The fair value of these instruments is
estimated based upon quoted market prices for identical instruments.
Equity securities carried at cost as a
measurement alternative
The non-recurring fair value measurement
is based on the valuation of the underlying investments on a new round of third party financing or upon liquidation.
Long-term debt and current portion of long-term
debt
The fair value of bank loans is determined
by estimating future cash flows on a borrowing-by-borrowing basis and discounting these future cash flows using the Company’s
incremental borrowing rates for similar types of borrowing arrangements.
The senior unsecured convertible bonds
have been trading on the open market segment of the Frankfurt Stock Exchange since their issuance on July 3, 2017. The fair value
of these instruments is the observable price of the bonds on that market.
Cash and cash equivalents, accounts receivable, short-term
borrowings, and accounts payable
The carrying amounts reflected in the consolidated
financial statements are reasonable estimates of fair value due to the relatively short period of time between the origination
of the instruments and their expected realization.
|
29.1
|
Nature of goods and services
|
The Company designs, develops, manufactures
and markets a broad range of products, including discrete and standard commodity components, application-specific integrated circuits
(“ASICs”), full-custom devices and semi-custom devices and application specific standard products (“ASSPs”)
for analog, digital and mixed-signal applications. In addition, the Company participates in the manufacturing value chain of Smartcard
products, which includes the production and sale of both silicon chips and Smartcards.
The principal activities – separated
by reportable segments – from which the Company generates its revenues are described in Note 30.
Other revenues consist of license revenue,
service revenue related to transferring licenses, patent royalty income, sale of scrap materials and manufacturing by-products.
While the majority of the Company’s
sales agreements contain standard terms and conditions, the Company may, from time to time, enter into agreements that contain
multiple performance obligations or terms and conditions. Those agreements concern principally the revenues from services, where
the performance obligation is satisfied over time. The objective when allocating the transaction price is to allocate the transaction
price to each performance obligation (or distinct good or service) in an amount that depicts the amount of consideration to which
the Company expects to be entitled in exchange for transferring the promised goods or services to the customer.
|
29.2
|
Revenue recognition and disaggregation
|
The Company recognizes revenue from products
sold to a customer, including distributors, when it satisfies a performance obligation at a point in time by transferring control
over a product to the customer. This usually occurs at the time of shipment. The performance obligations linked to the sale of
goods contracts have the original expected length of less than one year. The transaction price is determined based on the contract
terms, adjusted for price protection if applicable. The revenues from services are usually linked to performance obligations transferred
over time and are recognized in line with the contract terms.
The payment terms typically range between
30 and 90 days.
The Company’s consolidated net revenues
disaggregated by product group are presented in Note 30. The following tables present the Company’s consolidated net revenues
disaggregated by geographical region of shipment and nature.
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Net revenues by geographical region of shipment(1)
|
|
|
|
|
EMEA
|
549
|
613
|
1,727
|
1,861
|
Americas
|
326
|
315
|
990
|
922
|
Asia Pacific
|
1,678
|
1,594
|
4,085
|
4,233
|
Total revenues
|
2,553
|
2,522
|
6,802
|
7,016
|
|
|
|
|
|
Net revenues by Nature
|
|
|
|
|
Revenues from sale of products
|
2,521
|
2,491
|
6,679
|
6,885
|
Revenues from sale of services
|
26
|
24
|
100
|
93
|
Other revenues
|
6
|
7
|
23
|
38
|
Total revenues
|
2,553
|
2,522
|
6,802
|
7,016
|
|
|
|
|
|
Net revenues by market channel(2)
|
|
|
|
|
Original Equipment Manufacturers (“OEM”)
|
1,840
|
1,716
|
4,731
|
4,498
|
Distribution
|
713
|
806
|
2,071
|
2,518
|
Total revenues
|
2,553
|
2,522
|
6,802
|
7,016
|
|
(1)
|
Net revenues by geographical region of shipment are classified by location of customer invoiced
or reclassified by shipment destination in line with customer demand. For example, products ordered by U.S.-based companies to
be invoiced to Asia Pacific affiliates are classified as Asia Pacific revenues.
|
|
(2)
|
Original Equipment Manufacturers (“OEM”) are the end-customers to which the Company
provides direct marketing application engineering support, while Distribution customers refers to the distributors and representatives
that the Company engages to distribute its products around the world.
|
|
29.3
|
Practical Expedients and Exemptions
|
The Company does not disclose the value
of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts
for which the Company recognizes revenue at the amount to which the Company has the right to invoice for services performed.
The Company designs, develops, manufactures
and markets a broad range of products, including discrete and standard commodity components, application-specific integrated circuits
(“ASICs”), full custom devices and semi-custom devices and application-specific standard products (“ASSPs”)
for analog, digital, and mixed-signal applications. In addition, the Company further participates in the manufacturing value chain
of Smartcard products, which includes the production and sale of both silicon chips and Smartcards.
The Company’s reportable segments
are as follows:
|
·
|
Automotive and Discrete Group (ADG), comprised of dedicated automotive ICs (both digital
and analog), and discrete and power transistor products for all market segments.
|
|
·
|
Analog, MEMS and Sensors Group (AMS), comprised of low-power high-end analog ICs (both custom
and general purpose) for all markets, smart power products for Industrial, Computer and Consumer markets, Touch Screen Controllers,
Low Power Connectivity solutions (both wireline and wireless) for IoT, power conversion products, metering solutions for Smart
Grid and all MEMS products for sensors or actuators, subsystems, as well as the Imaging Products division (including the sensors
and modules utilizing the Company’s Time-of-Flight technology).
|
|
·
|
Microcontrollers and Digital ICs Group (MDG), comprised of general purpose and secure microcontrollers,
EEPROM memories, Digital ASICs, Aerospace & Defense products including components for microwave and millimeter wave.
|
For the computation of the segments’
internal financial measurements, the Company uses certain internal rules of allocation for the costs not directly chargeable to
the segments, including cost of sales, selling, general and administrative expenses and a part of research and development expenses.
In compliance with the Company’s internal policies, certain costs are not allocated to the segments, but reported in “Others”.
Those include impairment, restructuring charges and other related closure costs, management reorganization expenses, unused capacity
charges, phase-out and start-up costs of certain manufacturing facilities, certain one-time corporate items, strategic and special
research and development programs or other corporate-sponsored initiatives, including certain corporate-level operating expenses,
patent claims and litigations and certain other miscellaneous charges. In addition, depreciation and amortization expense is part
of the manufacturing costs allocated to the segments and is neither identified as part of the inventory variation nor as part of
the unused capacity charges; therefore, it cannot be isolated in the costs of goods sold. Finally, R&D grants are allocated
to the Company’s segments proportionally to the incurred R&D expenses on the sponsored projects.
Wafer costs are allocated to the segments
based on actual cost. From time to time, with respect to specific technologies, wafer costs are allocated to segments based on
market price.
The following tables present the Company’s
consolidated net revenues and consolidated operating income by reportable segment.
Net revenues by reportable segment:
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Automotive and Discrete Group (ADG)
|
894
|
901
|
2,682
|
2,588
|
Analog, MEMS and Sensors Group (AMS)
|
968
|
899
|
2,214
|
2,167
|
Microcontrollers and Digital ICs Group (MDG)
|
688
|
719
|
1,896
|
2,251
|
Total net revenues of product segments
|
2,550
|
2,519
|
6,792
|
7,006
|
Others
|
3
|
3
|
10
|
10
|
Total consolidated net revenues
|
2,553
|
2,522
|
6,802
|
7,016
|
Operating income by reportable segment:
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Automotive and Discrete Group (ADG)
|
76
|
116
|
244
|
289
|
Analog, MEMS and Sensors Group (AMS)
|
198
|
157
|
315
|
286
|
Microcontrollers and Digital ICs Group (MDG)
|
108
|
119
|
235
|
425
|
Total operating income of product segments
|
382
|
392
|
794
|
1,000
|
Others(1)
|
(46)
|
6
|
(51)
|
(44)
|
Total consolidated operating income
|
336
|
398
|
743
|
956
|
|
(1)
|
Operating results of “Others” include items such as unused capacity charges, impairment
& restructuring charges and other related closure costs, management reorganization expenses, phase out and start-up costs,
and other unallocated expenses such as: strategic or special research and development programs, certain corporate-level operating
expenses, patent claims and litigations, and other costs that are not allocated to product groups, as well as assembly services
and other revenue.
|
Reconciliation of operating income of segments
to the total operating income:
|
Three months ended
|
Nine months ended
|
|
September 28, 2019
|
September 29, 2018
|
September 28, 2019
|
September 29, 2018
|
Total operating income of segments
|
382
|
392
|
794
|
1,000
|
Impairment, restructuring charges and other related closure costs
|
-
|
-
|
(2)
|
(20)
|
Unallocated manufacturing results(1)
|
(40)
|
3
|
(48)
|
(2)
|
Strategic and other research and development programs and other non-allocated provisions(2)
|
(6)
|
3
|
(1)
|
(22)
|
Total operating loss Others
|
(46)
|
6
|
(51)
|
(44)
|
Total consolidated operating income
|
336
|
398
|
743
|
956
|
|
(1)
|
Includes unallocated unused capacity charges and start-up costs associated with our front-end manufacturing
facilities.
|
|
(2)
|
Includes unallocated income and expenses such as certain corporate-level operating expenses and
other costs/income that are not allocated to the product segments.
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
STMicroelectronics N.V.
|
|
|
|
|
Date:
|
November 4, 2019
|
By:
|
/s/ Jean-Marc Chery
|
|
|
|
|
|
|
Name:
|
Jean-Marc Chery
|
|
|
Title:
|
President and Chief Executive Officer and Sole Member of our Managing Board
|
Stmicroelectronics (PK) (USOTC:STMEF)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
Stmicroelectronics (PK) (USOTC:STMEF)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025